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Dissertation Abstract 
Anaplasma phagocytophilum is a tick-borne pathogen and the causative agent of 
Human Granulocytic Anaplasmosis (HGA). A. phagocytophilum is not transovarially 
transmitted from the mother to the progeny of infected ticks and therefore needs to 
survive in both a mammalian and the arthropod vector in order to complete its life cycle. 
To adapt to different environments, A. phagocytophilum relies on differential gene 
expression as well as the post-translational modification of proteins. However, little is 
known about what A. phagocytophilum genes and enzymes are required for the infection 
of human or tick cells. I used random mutagenesis to generate knock-out strains of Ap for 
functional genomics studies. One of the mutated strains presented an insertion within the 
coding region of an O-methyltranferase (OMT) family 3, which affects the ability of A. 
phagocytophilum to infect tick cells. Studies in the function of this enzyme suggest that it 
is involved in the methylation of an outer membrane protein (Major Surface Protein 4), 
which appears to be involved in bacterial binding and entry. The second mutant presents 
an insertion within the coding region of a hypothetical protein in the locus APH_0906 
and is unable to infect HL-60 cells and is impaired in its ability to grow in endothelial 
cells. Localization analysis of the protein showed that the protein is secreted into the 
cytoplasm and then translocated into the nucleus of host cells. Bioinformatic analyses 
demonstrated differences in Nuclear Localization Signals (NLSs) as well as binding 
residues within the protein homolog of human and non-human strains. Herein, I present 
the results from the functional analyses of both gene products. 
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Introduction  
 
Human Granulocytic Anaplasmosis (HGA)  
HGA, caused by Anaplasma phagocytophilum, is the second most frequently 
diagnosed tick-borne disease in United States after Lyme disease [1]. Like the Lyme 
disease agent, Borrelia burgdoferi, the etiologic agent of HGA, is maintained in nature in 
a transmission cycle involving small rodents such as mice, chipmunks and squirrels, and 
Ixodes spp. ticks [2,3]. A. phagocytophilum, the etiologic agent of HGA, infects 
peripheral blood phagocytes, specifically neutrophil granulocytes, and their progenitors 
in the bone marrow. A. phagocytophilum was previously known as Rickettsia 
phagocytophila, Cytoecetes phagocytophila, the Human Granulocytic Ehrlichiosis (HGE) 
agent, Ehrlichia equi or Ehrlichia phagocytophila before it was finally assigned to the 
genus Anaplasma [4,5]. HGA shares many symptoms, signs, and laboratory findings with 
diseases caused by other members of the family Anaplasmataceae, including high fever, 
headache, myalgia, malaise, thrombocytopenia, leukopenia, and elevated serum 
transaminases due to mild liver injury [6]. Additionally, respiratory and gastrointestinal 
manifestations are frequently reported. Following diagnosis, half of all patients require 
hospitalization and 7% of these require intensive care. The mortality rate is 0.5% - 1% , 
affecting mainly immunocompromised, elderly, or other people suffering from a pre-
existing condition [6-8]. Complications in HGA patients can include shock, clotting 
disorder, respiratory distress, myocarditis, renal failure, hemorrhage, and opportunistic 
infections [6,7].  
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Severity of the disease is independent of parasite load, and many of the signs and 
complications are due to the host’s inflammatory response [4,9], which causes lesions 
observed during HGA, and has been related to the over-expression of pro-inflammatory 
cytokines such as interferon gamma (IFN-γ) [9,10],[11]. The inflammatory response, 
accompanied by activation of NKT cells, is triggered by the polar lipid components of the 
bacterial outer membrane, and partially explains the histopathologic findings observed 
during infection with A. phagocytophilum [12]. Dysregulation of cytokine and chemokine 
production further affects differentiation of blood cells in the bone marrow during 
haematopoesis, and leads to the thrombocytopenia and leukocytopenia characteristic of 
the disease [13]. 
HGA is increasingly diagnosed in the USA, and has recently been diagnosed in 
Canada for the first time [14].  There has been a steady increase in the number and 
incidence of HGA cases [15], from 348 annual cases in 2000 to 1,761 reported in 2010, 
representing a rise from 1.4 cases per million to 6.1 cases per million [8]. The CDC [16] 
estimates that 88 % of HGA cases reported in the USA come from only 6 states, one of 
them Minnesota where a peak number of 788 cases was diagnosed in 2011 [17]. Clinical 
human cases have also been reported in Asia and Europe [6]. The first confirmed 
European case was diagnosed in Slovenia in 1997 [18], but the disease has remained 
relatively rare in that region, with just over  70 cases of HGA reported in Europe to date 
[reviewed in [19]. In some regions in Central Eastern Europe the sero-prevalence can be 
as high as 15.4 % [20], demonstrating frequent exposure of people living in endemic 
areas. In China and other Asian countries such as South Korea, seroprevalence of up to 
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20 % has been reported, and several HGA cases have been identified in individuals living 
within high risk areas [21-23].  
The most common drugs for treatment of HGA are the tetracyclines, especially 
doxycycline  that are considered the drugs of choice for all patients including pregnant 
women and children [1]. The CDC [1] recommends that treatment should be started 
before laboratory confirmation is obtained as complications are more likely to occur 
when treatment is delayed.  
 
Anaplasmosis in domestic and wild animals 
The principal natural mammalian reservoir of A. phagocytophilum in the USA are 
small rodents, including white-footed mice (Peromyscus leucopus), chipmunks, squirrels 
and woodrats [3,44, 45].  However, A. phagocytophilum has been detected in other 
rodents such as southern red backed voles, short tailed shrews, meadow jumping mice, 
and meadow voles. Analysis of 16S rDNA and other genes (e.g., ankA) suggested that 
mouse and human isolates were similar, but those from woodrats were distinct. 
Moreover, A. phagocytophilum variants found in woodrats did not infect horses, whereas 
chipmunk and human origin A. phagocytophilum did [24].  
Tick-borne fever (TBF) in sheep and pasture fever in cattle caused by A. 
phagocytophilum has been known in Europe for at least 200 years [25,26]. In the UK, it 
was estimated that at least 300,000 lambs develop TBF per year [26], over half of all 
lambs in Southern Norway tested seropositive [27], and it ranked third as a cause of 
abortion in sheep in northern Spain [28],  indicating it is wide-spread in Europe. In 
addition, molecular and immunological evidence of A. phagocytophilum infection in 
5 
 
 
wild-ruminants, especially deer, has been widely reported in several countries in Europe, 
North America and Asia [26,29,30]. Ruminant variants of A. phagocytophilum associated 
with TBF in Europe have not been found associated with human disease, which is similar 
to the Ap-Variant 1 isolated from ticks in Rhode Island and Minnesota that has been 
found to infect only ruminants [31-35]. Indeed, a human isolate of A. phagocytophilum 
(NY-18) was unable to persistently infect white-tailed deer when injected intravenously 
[33], whereas deer injected with the Ap-Variant 1, an A. phagocytophilum strain 
associated with deer, remained positive for 65 days by IFA and 25 days by PCR [33]. A. 
phagocytophilum strains similar to Ap-Variant 1 appear to be more abundant in ticks 
when compared to human strains. This has led to the hypothesis that the high presence of 
ruminant variants may explain the low rates of human infections in Europe and in some 
endemic regions in the USA [30]. 
A. phagocytophilum also infects other domestic animals such as dogs, cats, and 
horses [25,26], and wild animals, such as wild boar, red and gray foxes, opossums, and 
raccoons [36] [25]. The highest prevalence of A. phagocytophilum in dogs in the USA 
has been documented in the upper Midwest (6.7 %) and the Northeast (5.5 %), and can 
reach 50 % in some regions of Wisconsin, Minnesota, and Massachusetts [37]. Infection 
of dogs with A. phagocytophilum has also been detected in other countries, including 
Brazil, Slovakia, France, Germany, and South Korea [38-42]. Most infected dogs develop 
fever, lethargy, anorexia, and sometimes diarrhea and coughing [reviewed in [43]. 30 % 
of the domestic cats from endemic areas in the northeastern USA had serum antibodies 
against A. phagocytophilum [44], but prevalence of clinical disease in cats is actually low 
(4.3 %) [45]. Even though experimentally cats developed fever and  8 % of neutrophils 
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contained morulae, anorexia and lethargy were not present [46]. Phylogenetic analysis of 
the variants infecting horses, dogs, and cats, showed that they were closely related to 
human pathogenic variants, although analysis of the abundance of these variants in tick 
populations demonstrated that they were rare in the regions where the cases were 
reported [47].  
 
Anaplasma phagocytophilum 
A. phagocytophilum is a small, gram negative bacterium in the family 
Anaplasmataceae within the order Rickettsiales around 0.4 X 2.0 µm in size that is 
enveloped by two membranes (reviewed in [48]). Members of the family 
Anaplasmataceae have lost the genes involved in biosynthesis of lipopolysaccharide 
(LPS) and peptidoglycan, thus they escape recognition by Toll-like receptors (TLR) and 
do not present pathogen-associated molecular patterns (PAMPs) that stimulate the innate 
immune response of mammals and invertebrates [49]. A. phagocytophilum grows in 
membrane-bound inclusions called “morulae”, unlike members of the family 
Rickettsiaceae that replicate directly in the cytosol of cells  [49]. The most abundant 
protein of Anaplasma phagocytophilum is outer membrane protein MSP2 (P44), which is 
involved in a mechanism of antigenic variation that facilitates persistent infection [50]. 
MSP2 (P44) has been proposed to act as a porin [51] that is formed by dimers and 
oligomers of several interacting P44s [52], and may act as an adhesin to human 
granulocytes [53]. This protein is highly upregulated during growth in mammalian cells 
as compared to growth in tick cells (>10 fold up-regulation) [54], suggesting that the 
function of this protein is specific to mammalian cells. Other proteins that have been 
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detected as part of the outer membrane of A. phagocytophilum included APH_0441, 
OMP85, APH_0404, APH_0405, several P44 paralogs, and OMP1-a [55]. Two of these 
proteins, APH_0404 and APH_0405, were shown to be involved in infection as pre-
treatment with monoclonal antibodies against these proteins prevented internalization of 
the bacteria [55]. 
In addition to proteins, A. phagocytophilum incorporates cholesterol obtained 
from the host cell into its outer membrane, since it lacks genes involved in the synthesis 
and/or modification of cholesterol [56]. Host derived cholesterol was required for the 
integrity of the outer membrane of both A. phagocytophilum and the related tick-borne 
pathogen Ehrlichia chaffeensis. Treatment of host cell-free bacteria with Methyl-β-
cyclodextrin (MβCD) to extract cholesterol disrupted the bacterial membrane integrity 
and prevented invasion of host cells [56]. The replacement of cholesterol with NBD-
cholesterol, a non-functional fluorescent analogue, also affected the ability of the bacteria 
to infect and survive within host cells [56].  
A. phagocytophilum has a relatively small genome with only 1.47 Mb and 1,369 
open reading frames (ORFs), 45 % of which encode hypothetical proteins (82 ORFs 
represent conserved hypothetical proteins and 458 ORFs encode hypothetical proteins 
unique to this organism). There is no evidence that A. phagocytophilum harbors plasmids 
or transposons and only a few phage components are found in its genome. Several of the 
hypothetical proteins have been suggested to be part of the outer membrane or to be 
components of the type 4 secretion system (T4SS) of the bacteria (reviewed in [48]). Like 
other members of the Rickettsiales, A. phagocytophilum has undergone  reductive 
evolution, which explains the need for a host cell to provide essential functions [57]. A. 
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phagocytophilum has evolved to survive in two completely different environments, the 
mammalian host and the tick vector. This has been accomplished, in part, through 
differential use of its genome and expression of certain genes only during residence in a 
specific environment [54].  The differences in development and gene expression in each 
host cell type are described below. 
 
A. phagocytophilum in neutrophils 
A. phagocytophilum infects mammalian neutrophil granulocytes and their 
progenitors by using the α-(1,3) fucosylated P-selectin glycoprotein ligand-1 (PSGL-1) 
for entry [58]. A. phagocytophilum binds to the N-terminal region of PSGL-1 and to 
sialyl Lewis x (sLex) through interactions with α2,3- sialic acid and α1,3- fucose. 
However, pretreatment of HL-60 cells with antibodies against PSGL-1 (KPL1), the N-
terminal amino acid sequence of PSGL-1 (mAb PL1), and sLex mAbs, or treatment with 
sialidase did not completely prevent binding of A. phagocytophilum, indicating that an 
alternative adhesin exists that interacts with a different ligand [58,59]. This was 
confirmed using HL-60 cells deficient in sLex (HL-60 sLex-low) to enrich for bacteria that 
do not require this ligand [59]. These sialic acid-independent bacteria showed a reduced 
ability to bind to wild-type HL-60 cells, however, when HL-60 cells were pretreated with 
the antibodies mentioned above, sialic acid-independent A. phagocytophilum exhibited 
greater binding and internalization than wild-type populations [59]. This sialic acid-
independent A. phagocytophilum population supports the notion that an alternate adhesin 
protein exists but is underrepresented in the bacterial outer membrane. Two proteins have 
been identified as possible adhesins interacting with PSGL-1, OmpA [60] and Asp14 
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(Aph_0248) [61]. Biotinylation of the outer membrane of A. phagocytophilum indicated 
that these proteins were abundant in dense core (DC) bacteria along with P44 [61]. 
Expression of both proteins was up-regulated in bacteria binding to neutrophils, and 
preincubation of the bacteria with serum against either protein interfered with infection 
[60,61]. Likewise, incubation of HL-60 cells with recombinant versions of OmpA and 
Asp14 reduced the number of bacteria infecting HL-60 cells by 50 % [60,61]. Although 
three possible invasins have been identified, it is very likely that as yet unidentified 
proteins are involved in adhesion of A. phagocytophilum to neutrophils and endothelial 
cells [reviewed in [62]. 
It has been suggested that A. phagocytophilum does not enter neutrophils by 
phagocytosis, but instead actively invades cells via caveolae mediated endocytosis [63]. 
There is evidence that PSGL-1 interacts with a cytoplasmic tyrosine kinase (Syk) and 
ROCK1, a kinase that co-localizes with caveolae, to support entry of A. phagocytophilum 
into the cell [64] as cells treated with rock1 siRNA did not efficiently internalize A. 
phagocytophilum [64]. Alternatively, activation of Syk may promote cytoskeleton 
rearrangement that induces phagocytic uptake of the bacteria [65].  Also, A. 
phagocytophilum requires lipid rafts or proteins concentrated in lipid microdomains, such 
as Caveolin-1, Glycosylphosphatidylinositol anchored proteins (GAPs) and flotillin 1 for 
internalization (reviewed in [48]). A recent study proposed that A. phagocytophilum was 
able to sequester Rab proteins, such as Rab10, Rab11A, Rab14, and other Rab proteins to 
acquire amino acids and possibly cholesterol, and to coat the vacuolar membrane of the 
inclusion in which the bacterium develops, thus preventing maturation of the vacuole and 
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lysosomal fusion [66]. Rab proteins are involved in regulating endocytic recycling and 
transport of vesicles in the slow clathrin-independent pathway [66].  
Like other members of Anaplasmataceae, such as Anaplasma marginale and 
Ehrlichia chaffeensis, A. phagocytophilum undergoes a biphasic developmental cycle, 
alternating between dense-cored (DC) forms 0.6-0.8 µm in width, which possess a dense 
nucleoid and a ruffled outer membrane, and larger reticulated forms (RC) [65]. Only the 
DC form of the bacteria bound to and was internalized by HL-60 cells into cell-derived 
vacuoles. By 12 hr DC forms were less frequent and most of the pathogens occupying 
vacuoles had changed into RC. RC bacteria replicated, presented dispersed nucleoids and 
smoother outer membranes, and measured between 0.69+0.36 µm and 1.04+0.44 µm in 
size. By 24 hr, differentiation into DC cells occurred, and bacteria were released from 
host cells, completing the developmental cycle of A. phagocytophilum in neutrophils. 
However, the mechanism whereby bacteria are released from the host cell remains 
unknown. 
The vacuole where A. phagocytophilum develops presents hallmarks of an 
autophagosome, such as a double-lipid bilayer and colocalization with LC3-II and Beclin 
1 [67]. Moreover, treatment of HL-60 cells with 3-MA, a pharmacological inhibitor of 
autophagosome formation, inhibited of A. phagocytophilum replication [67]. Three 
hypothetical proteins from A. phagocytophilum have been shown to be associated with 
the formation of the vacuole APH_0233, APH_1387, and APH_0032 [reviewed in [48]. 
Both APH_0032 and APH_1387 are acidic proteins that contain several repeats. 
APH_0032 possesses eight repeats in its C-terminal domain that consist of nearly 
identical sequences of 33 to 35 amino acids [68], whereas APH_1387 has only 3 tandem 
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repeats of 93 – 130 amino acids consisting mostly of amphipathic alpha helices with 
similarity to chlamydial Inc proteins [69]. Both proteins are secreted into the vacuole, 
however, APH_1387 is expressed by RC bacteria, whereas APH_0032 is expressed by 
DC organisms [68,69]. Both proteins appear to colocalize with the vacuole membrane in 
mammalian and tick cells, but their function is not known [68,69].  APH_0233, also 
known as AptA, interacts with vimentin, a filament protein associated with 
phosphorylated Erk1/2 that is localized around the bacterial inclusions [70].  AptA is 
preferentially expressed during infection of mammalian cells [54,70], is incorporated into 
both bacterial and vacuolar membranes, and has been proposed to aid in the acquisition 
of lipids from the host cell [54,70].  All these proteins probably interact with host cell 
proteins and modify the vacuole to promote replication of the bacteria.   
One of the host proteins that seems to be associated with the bacterial vacuole 
appears to be ubiquitinated. Ubiquitin typically modifies lysine residues on target 
eukaryotic proteins after translation [71]. The ubiquitination of vacuole proteins starts 4 
hr p.i. during vacuole formation and increases for up to 18 hr decreasing after 24 hr p.i. 
probably after the morulae has become “mature.” Similar to Rab GTPases, colocalization 
of ubiquitinated proteins with the bacterial inclusion depends on A. 
phagocytophilum protein synthesis as ubiquinization is reduced with tetracycline 
treatment. Mono-ubiquitination of the inclusion membrane is also observed in RF/6A 
cells, but is reduced in ISE6 cells [71]. Ubiquitination may avoid lysosomal targeting of 
the morula by the host cell, preventinf destruction of the bacteria. 
A. phagocytophilum has evolved ways to escape destruction by the phagocytic 
machinery of neutrophils [72]. Infected neutrophils are unable to adhere to endothelium, 
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transmigrate and generate phagocyte oxidase, and are deficient in anti-microbial activity 
[73]. Infection with A. phagocytophilum stimulates NADPH oxidase production in 
neutrophils but this does not result in an increase of reactive oxygen species (ROS). 
Apparently, the bacteria are able to scavenge superoxide (O2-) by some heat-labile 
surface protein [63], a mechanism that is important during early entry of A. 
phagocytophilum into the neutrophil when the bacteria stimulate cellular activation and 
O2- release [63]. After internalization, A. phagocytophilum is relocated into a vacuole that 
excludes NADPH oxidase and does not acquire gp91phox and p22phox [63]. Infection with 
A. phagocytophilum resulted in the reduction of PU.1 and Interferon Regulatory Factor 1 
(IRF1) concentrations in nuclear extracts of HL-60 cells, in turn causing enhanced 
binding of the CCAAT displacement protein (CDP) that acts as a repressor in the 
promoter region, resulting in inhibition of gp91phox expression [74]. Although all 
members of the Rickettsiales contain sodB, encoding an iron superoxide dismutase that 
protects against intracellular ROS produced during metabolic activities, and which is 
probably injected into the host cytosol by the type IV secretion system [75], it is not 
involved in defense against extracellular ROS. 
A. phagocytophilum infection of neutrophils furthermore reduces their ability to 
adhere to endothelial cells, which results from the degranulation induced by A. 
phagocytophilum [76]. bacterial binding to E-selectin during infection reduces PSGL-1 
and L-selectin expression in neutrophils and decreases the calcium flux that normally 
occurs during PMN activation during rolling [77,78]. Reduced E-selectin-mediated 
adherence to endothelium suppresses p38 MAPK phosphorylation, which is necessary for 
arrest and directional transmigration [77]. It has been suggested that the resulting 
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increased availability of infected neutrophils circulating in the blood stream enhances 
acquisition by ticks during feeding [78]. A. phagocytophilum are able bind to neutrophils 
even after they have engaged in rolling under shear in a flow chamber, which may reflect 
how bacteria and uninfected neutrophils initially make contact in a mammalian host [77]. 
Inflammation of microvascular endothelium at the tick bite site attracts neutrophils that 
would come into contact with bacteria that were released into the bite wound by feeding 
ticks and had infected microvascular endothelial cells in the area. This is plausible 
considering that neutrophils do not return to the lumen of blood vessels once they have 
completed extravasation, and provides a mechanism for infection of neutrophils that does 
not require their transmigration [79]. 
There is some disagreement about the transcriptional response of of neutrophils 
during infection with A. phagocytophilum, however upregulation of 
cytokines/chemokines, such as IL-8 (involved in inflammation response) and IL-1β 
(involved in cell adhesion to endothelial cells), as well as transcriptional regulator 
molecules has been reported by several researchers [72,78,80,81]. A central theme 
observed is global inhibition of pro-apoptotic pathways through manipulation of 
mitochondrial responses including the p38MAPK and ERK signaling pathways, as well 
as inhibition of the Fas-induced pathway of apoptosis involving TNFAIP3, CFLAR, and 
SOD2. At the same time, there is induction of anti-apoptotic genes collectively allowing 
prolonged circulation of infected neutrophils in peripheral blood to make them available 
for acquisition by feeding ticks [72,80,81]. Thus A. phagocytophilum appears to 
manipulate both the intrinsic (mitochondrial) and extrinsic (death receptor) pathways  
[81].  
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Other cells infected by A. phagocytophilum 
 Experimental infection of mice has demonstrated dissemination of A. 
phagocytophilum to multiple tissues including skin, lungs, kidney, liver, spleen, lymph 
nodes, and bone marrow, suggesting that cells other than granulocytes become infected, 
e.g., endothelial cells, megakaryocytes and mast cells [82]. In support of this hypothesis, 
A. phagocytophilum causes persistent infections in ruminants with periodically recurrent 
bacteremias [83]. Also endothelial cell lines, such as RF/6A (American Type Culture 
Collection, Manasssas, VA, USA; ATCCCRL-1780) from the retina choroid of a normal 
fetal rhesus monkey (Macaca mulatta) and the human microvascular endothelial cell line 
HMEC-1, support continuous replication of A. phagocytophilum [84]. The appearance of 
A. phagocytophilum in endothelial cells differs from that observed in HL-60 cells or 
neutrophils, since colonies of bacteria within endothelial cells are smaller and more 
numerous, and individual bacteria are always distinguishable [84]. Transfer of A. 
phagocytophilum between infected HMEC-1 cells and human neutrophils occurred 
rapidly and was highly effective [85]. The closely related bovine pathogen A. marginale 
infected endothelial cells in vitro, and in the kidney of an experimentally infected calf A. 
marginale colocalized with von Willebrand factor VIII, an endothelial marker [86]. Even 
though in vivo infection of blood vessel endothelial cells with A. phagocytophilum has 
not been demonstrated, it is very likely that this bacterium does in fact infect 
microvascular endothelium, especially around the tick bite site.   
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A. phagocytophilum in ticks 
 A. phagocytophilum is transmitted exclusively by members of the Ixodes ricinus 
complex. In the Northeast and Midwest and the Westcoast states of the USA, Ixodes 
scapularis (the black-legged tick) and Ixodes pacificus (the western black-legged tick), 
respectively, are the vectors, and in Europe and Asia, A. phagocytophilum is transmitted 
by Ixodes ricinus and other ticks in the Ixodes persulcatus complex, including I. 
persulcatus Ixodes ovatus [87]. However, it has also been found associated with other 
tick species, such as Haemaphysalis punctata, Riphicephalus sanguineus, and 
Dermancentor reticulatus [reviewed in [25], [88]]. It has been estimated that in endemic 
areas of the USA, 10 – 50 % of I. scapularis ticks are infected with A. phagocytophilum, 
and the proportion of infected I. ricinus in Europe is similar, at 2 – 45 % [reviewed in 
[8]]. Ixodes ticks cannot transmit A. phagocytophilum transovarially from one generation 
to the next, and immature ticks must reacquire the bacteria with an infected blood meal to 
maintain natural transmission cycles [reviewed in [8]]. A comparison of the genomes of 
the Anaplasmataceae with those of the Rickettsiaceae that are transmitted transovarially, 
revealed absence of a class II aldolase/adducing domain protein in the Anaplasmataceae, 
which was hypothesized to enable transovarial passage in the Rickettsiaceae [75]. 
Transovarial transmission of A. phagocytophilum was reported in Dermacentor albipictus 
(winter tick), as 42 % of larval progeny of infected ticks collected from deer were also 
infected, as demonstrated by PCR and sequencing. However, transovarial transmission to 
F2 larvae did not occur [89]. The A. phagocytophilum strains infecting these ticks were 
WI-1 and WI-2, which are believed to be non-pathogenic to humans, similar to Ap-
Variant 1 [89]. This is the only evidence supporting transovarial transmission of A. 
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phagocytophilum, although the low efficiency of transovarial maintenance confirms the 
need for the pathogen to infect mammalian hosts in order to maintain its life cycle in 
nature.   
 Acqusition of A. phagocytophilum began within the first 24 hr of tick feeding, but 
the percentage of infected ticks continued to increase substantially until time of de-
attachment. Subsequently, the number of infected ticks in a cohort declined, while the 
number of bacteria within individual ticks increased [90]. Under controlled experimental 
conditions, the time required for transmission of A. phagocytophilum to naïve mice was 
40 to 48 hrs, suggesting that bacteria must replicate to reach optimal numbers for 
transmission to occur [90]. The development of A. phagocytophilum and its tissue 
tropism in the vector has not been described, and only one study demonstrated A. 
phagocytophilum in gut muscle, salivary glands and the synganglion of adult ticks [33]. 
Although the presence of A. phagocytophilum in hemocytes was interpreted to indicate 
their involvement in the transport of the bacteria to different organs, it is also possible 
that this resulted from phagocytosis as a defense against the bacteria [91]. The only 
detailed description of the development of A. phagocyophilum in tick cells so far is 
available from in vitro studies using a tick cell line, ISE6, derived from the vector. The 
development of A.phagocytophilum in tick cell culture was similar to that observed in 
human cell culture, and proceeded from invading dense forms (DC) to RC forms that 
replicated inside large morulae until differentiation into DC and release from cells by 4 
days when the cycle began anew [92]. Major differences in the development in tick cells 
versus human cells included that individual inclusions were much larger, there were only 
a few (usually one to three) in each host cell, and completion of the developmental cycle 
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took nearly twice as long [65]. Some morulae within tick cells contained so many A. 
phagocytophilum that individual bacteria were hard to discern [92]. 
A. phagocytophilum recognizes and binds to specifically glycosylated ligands on 
neutrophil granulocytes during infection of mammalian cells [58,93]. It is interesting that 
A. phagocytophilum utilizes platelet selectin glycoprotein-1 (PSGL-1) that must be both 
α-2,3-sialylated and α1,3-fucosylated to invade human neutrophils. The as yet unknown 
mouse-receptor is distinct from PSGL-1, but must also be α1,3-fucosylated while α-2,3-
sialylation is not required [93]. Similarly, α1,3-fucosylation of an unidentified ligand was 
required for acquisition of A. phagocytophilum by I. scapularis ticks, and for colonization 
of I. ricinus cells, but not for tick-transmission to mice [94]. Possibly, utilization of 
PSGL-1 is a recently acquired trait in A. phagocytophilum and may play a role in 
pathogenesis of human anaplasmosis by altering the pro-inflammatory response of 
neutrophils [95]. By comparison, utilization of α1,3-fucosylated moieties that participate 
in infection of diverse organisms by A. phagocytophilum appears to be a more anciently 
conserved mechanism.   
A. phagocytophilum was shown to interact with or take advantage of I. scapularis 
proteins to infect and probably mobilize within the tick. Two of these proteins, P11 
(DQ066011) and Salp16, were upregulated in infected vs uninfected ticks. They 
specifically affected transfer of A. phagocytophilum to salivary glands but not 
colonization of the midgut, and appeared to be secreted by salivary gland cells or 
possibly hemocytes (P11) [48]  While these studies demonstrated the specific 
requirement of the proteins for colonization of tick salivary glands by A. 
phagocytophilum using RNAi, their function in ticks and the ligands or receptors 
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involved in their interaction with A. phagocytophilum remain undefined. Not 
unexpectedly, proteins that were required for efficient tick engorgement, oviposition, or 
survival, such as subolesin, also impacted A. phagocytophilum infection of tick salivary 
glands [96]. It is likely that these interactions were not specific to the pathogen.  
An analysis of data obtained from infected I. scapularis processed during 
transmission feeding revealed a small set of A. phagocytophilum-transcripts using liquid 
chromatography tandem mass spectrometry (LC MS/MS) and RNA-Seq. The authors 
hypothesized that the reason for this limited number of active genes detected was due to 
the fact that at that time, only DC bacteria were present [97]. However, whether DC A. 
phagocytophilum are truly inactive awaits conclusive analysis, and it is also possible that 
there were not sufficient numbers of bacteria in the samples. The fact that several 
structural ribosomal proteins were identified supports this. Further, the biphasic 
development of the intracellular bacterial pathogen, Chlamydia trachomatis, includes a 
dense form referred to as “elementary body” that had long been assumed to be 
metabolically dormant, but was recently shown to be as active as C. trachomatis RC cells 
[98]. Nonetheless, several A. phagocytophilum outer membrane proteins thought to be 
involved in mammalian cell invasion, such as OMP-1a and MSP2/P44, as well as stress 
response proteins were detected in the feeding ticks, and likely represented a subset of 
those mediating the transition from the tick vector to the mammalian host [97].   
It is difficult to identify specifically interacting ligands and receptors, or other 
proteins and factors involved in infection and development of A. phagocytophilum using 
whole ticks. Our laboratory applied transcriptomics based on whole genome tiling 
microarrays to identify 41 A. phagocytophilum genes that were only expressed during 
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infection of tick cells but not mammalian cells in vitro [54]. Three of these were known 
such as msp4 (Aph_1240) encoding major surface protein 4, but over 90 % were 
identified as genes encoding hypothetical proteins, demonstrating how little is known 
about the biology and the proteins involved in tick-A. phagocytophilum interactions [54]. 
For this study, RNA was harvested from cultures in which > 90 % of cells were infected, 
representing transcripts from late phases of infection (during intracellular development 
and exit from cells) [54] and thus genes involved in early phases of infection, such as 
binding and cell entry, were likely missed.  Thus, there is a big gap in knowledge of the 
factors that are important during tick infection, especially those important during binding 
and cell entry, which are part of the focus of the studies presented in this dissertation.  
 
A. phagocytophilum effectors  
Several pathogens have evolved the ability to hijack the host cell machinery in 
order to ensure their survival. For example, the pathogen Legionella pneumophila 
possesses 270 effectors that have been verified experimentally and many of which have 
been shown to modulate host immune response, regulation of cell death, and gene 
expression [99]. Likewise, A. phagocytophilum controls apoptosis, reduces neutrophil 
phagocytosis and adherence to vascular endothelium, and affects other host cell functions 
by interfering with signaling pathways and by manipulating gene expression with 
secreted factors, i.e., effectors [100]. To secrete these effectors bacteria have evolved 
different secretion systems [reviewed in [48]], outer membrane vesicles [101], and 
translocases, such as TAT systems (Twin Arginine Translocation) [102]. One such 
effector is AnkA, a protein that is secreted into the host cell cytoplasm, probably by the 
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type 4 secretion system (T4SS, encoded by the VirB/D4 locus) of A. phagocytophilum. 
AnkA subsequently translocates to the nucleus to control host innate immune responses 
by binding diverse partners such as nuclear proteins, ATC-rich sequences, regulatory 
regions of genes including CYBB (encoding gp91(phox)), and to internucleosomal 
linkers which could stabilize DNA to interfere with progression of apoptosis [100]. 
Optimal AnkA delivery depended on engagement of PSGL-1, resulting in 
phosphorylation of this protein within minutes of attachment to a cell [103].  A. 
phagocytophilum AnkA decreased acetylation of histone 3 (H3) by stimulating the 
expression of HDAC1 and HDAC2, leading to the hypothesis that AnkA may induce 
epigenetic changes in the host by altering chromatin structure [104]. This hypotheis is 
supported by the similarity of AnkA with SATB-1, a protein known to interact with 
HDAC1, and the fact that AnkA binds to promoters within the H3 deacetylated region  
[104].  
It is thought that A. phagocytophilum encodes many other effectors responsible 
for manipulation of host cell’s processes [105]. However, only one additional effector 
protein has been described in A. phagocytophilum, i.e., APH_0859, designated Ats-1 
(Anaplasma translocated substrate 1). The protein accumulated within the A. 
phagocytophylum inclusion starting one day after infection, and was secreted into the 
cytoplasm of HL-60 cells 32 hr pi [105], whereupon Ats-1 was transported to the 
mitochondria. This process was independent of any other bacterial factors as the protein 
also co-localized with mitochondria when expressed in transfected RF/6A cells. Instead, 
translocation depended on the presence of an N-terminal sequence to direct it to 
mitochondria, as its deletion resulted in diffuse distribution within the cytoplasm [105].  
21 
 
 
However, not all of Ats-1 is directed to mitochondria, but was shown to sequester 
Beclin1, and subsequently recruited endoplasmic reticulum (ER) proteins to induce 
formation of autophagosomes that transported nutrients to the A. phagocytophilum 
vacuole in HL-60 cells and RF/6A cells [106].   
Both AnkA and Ats-1 are secreted through the  T4SS, and although A. 
phagocytophilum also encodes T1SS, Sec, and TAT systems, no substrates that utilize 
these have been identified  (reviewed in [48]). Even though conserved motifs of secreted 
proteins have not been demonstrated in either AnkA or Ats-1, both have been shown to 
share characteristics with secreted proteins in other bacterial species such as a net 
positive charge and characteristic hydropathy profiles [107]. These proteins represent two 
mechanisms that A. phagocytophilum exploits to assure its own survival and extend the 
life span of its host cell, thus increasing the chances of acquisition by feeding ticks to 
complete its life cycle. It is very likely that A. phagocytophilum possesses many other 
effector molecules that have not been identified to date. Identification of these effectors 
and their function during host infection is crucial for understanding the mechanisms of 
pathogenesis of human anaplasmosis, and for the discovery of alternative treatments.  
 
A. phagocytophilum functional genomics 
 To date, research on A. phagocytophilum biology has relied on proteomics 
analysis involving procedures such as immune-precipitation, biotinylation of outer 
membranes, and Western blots. In addition, microarrays and RNA-Seq have shed light on 
gene expression of the bacteria during replication in various host cells. However, these 
techniques may overlook proteins that are not as abundant as outer membrane proteins or 
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genes that are only expressed at specific times during development. For example, 
expression arrays will likely miss activity of important non-coding regions in the 
genome, like promoters, enhancers, and silencers that may be important for the 
pathogenesis of human anaplasmosis. Because of the intracellular nature of A. 
phagocytophilum, functional genomics studies based on mutagenesis are difficult. 
However, recent progress in transposon mutagenesis of A. phagocytophilum using the 
himar1 transposase [108], has opened the possibility of applying random mutagenesis to 
study gene function in A. phagocytophilum. Transposon mutagenesis has led to 
identification of a gene encoding a dihydrolipoamide dehydrogenase 1 (Ldpa1), 
APH_0065, that facilitates infection of neutrophils, and stimulates secretion of IFN-γ and 
macrophage activation during mouse infection. This mutation led to a stronger 
inflammatory response and greater ROS production in mouse macrophages, but did not 
affect pathogen load in tissues. This indicated that Ldpa1 was responsible for reducing 
ROS and pro-inflammatory cytokine production in macrophages, which was shown to 
play a role in pathogenesis of human anaplasmosis [10]. This was the first report of a 
mutation of an A. phagocytophilum gene that allowed identification of its potential role 
during infection of and survival in the mammalian host. Since then, the himar1 
transposase system has been used to generate additional mutants, and here I present my 
results from experiments to determine the exact function of two genes during infection of 
human and tick cells. 
 
Methyltransferases and infection 
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 The importance of protein modifications for virulence of bacteria and other 
pathogens has been a subject of increased interest, especially since it has been discovered 
that the properties and functions of proteins change depending on the modifications they 
have undergone [reviewed in [109]. Such modifications include phosphorylation, 
acetylation, pupylation (modification by a prokaryotic ubiquitin-like protein), 
carboxylation, glycosylation, deamination, and methylation [reviewed in [109]. During 
methylation, a methyltransferase adds a methyl moiety obtained most commonly from S-
adenosine-methionine (SAM) to a receiving atom [110]. Methyltransferases modify 
proteins, DNA, RNA, co-factors, xenobiotics, lipids, and other types of molecules in 
plants and mammalian, however, the importance of this modification in bacterial and 
viral infection has only been discovered recently [111-114]. Protein methylation occurs in 
two different forms, N-methylation of lysines, arginines, and glutamine and O-
methylation of glutamic acid [as reviewed in [109], and has been shown to be important 
in several bacterial processes, including chemotaxis and signal transduction [111], 
binding to and invasion of host cells [115], and toxin production [116].  
Two examples of O-methyltransferases are CheR and CheB methyltransferases, a 
O-methyltransferase involved in the modification and activation of chemoreceptors in E. 
coli, Salmonella thyphimurium, and Pseudomonas putida to facilitate chemotaxis, as well 
as biofilm and pili formation [111]. Chemoreceptors and chemotaxis are important for 
bacterial adaptation to different environments, and bacteria use methylated sensors in 
their outer membrane to detect external stimuli [111]. Lateral transfer of genes encoding 
methyltransferases may enable development of pathogenicity, or, bacterial evolution 
towards pathogenicity may shape methyltransferases in similar ways. Pathogenic strains 
24 
 
 
of bacteria harbor O-methyltransferases that are more similar to those in unrelated 
pathogenic bacterial species than to those found in non-pathogenic relatives, thus linking 
the presence of these enzymes with virulence and pathogenesis [117]. O-methylation of 
bacterial adhesins is an important modification, and methylation of an outer protein in 
Leptospira interrogans was necessary for adhesion to and colonization of epithelial cells 
in hamster kidneys [118]. Similarly, methylation of OmpB is necessary for binding to 
endothelial cells by Rickettsia prowazekii and Rickettsia typhi, even though this appears 
to involve a different kind of methyltransferase [119,120]. However, little is known about 
the role of methylation in the virulence and pathogenesis of A. phagocytophilum or any 
member of the Anaplasmataceae family. 
 
Conclusion 
 Human Granulocytic Anaplasmosis (HGA) has rapidly become the second most 
important tick-borne disease, and probably the third most important vector-borne disease, 
in the USA, and is gaining importance in Europe and Asia. This disease represents an 
important risk especially for people with immunological deficiencies. Furthermore, this 
disease not only represents an important burden in human health, but also affects the 
sheep and cattle industries of several European countries. There is no vaccine, and 
treatment relies on tetracycline antibiotics. Therefore, it is important to find other 
possible ways of treatment and prevention of the disease, which can only be obtained 
through the understanding of the pathogen’s biology and life cycle and the molecules that 
are involved in the infection process. Important advances have been obtained in this 
regard, but they are minimal when compared to other pathogens, largely because of the 
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obligately intracellular life of A. phagocytophilum. This is especially true in our 
understanding of the vector-pathogen-host interfaces of the disease. Adaptation of the 
himar1 transposase tool for random mutagenesis of A. phagocytophilum may help 
overcome this lack of understanding. This dissertation describes studies to elucidate the 
functions of two genes, which were mutated using the himar1 transposon tool, in 
adhesion, invasion and replication of A. phagocytophilum in host cells.  The two mutant 
strains are deficient in their abilities to infect either human or tick cells. One of the 
mutants has insertion into an O-methyltransferase gene (omt) that prevents the pathogen 
from binding to and invading tick cells. The analysis presented herein suggests that the 
OMT methylates an outer membrane protein of A. phagocytophilum that mediates 
adhesion to tick cells. The second mutant has an insertion into a gene encoding a 
hypothetical protein, APH_0906, which may be an effector that is secreted into the host 
cytoplasm and translocated into the nucleus.  Mutational analysis of gene function in A. 
phagocytophilum is now available for mechanistic studies to determine how this 
bacterium is able to cycle between tick vectors and mammalian hosts. 
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Chapter 2 
 
 
 
Identification of two genes involved in the infection process of the tick-borne pathogen 
Anaplasma phagocytophilum 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
 
Introduction 
 
Anaplasma phagocytophilum is an obligately intracellular bacterium classified in 
the order Rickettsiales and is the causative agent of Human Granulocytic Anaplasmosis 
(HGA) [121]. HGA is characterized by high fevers, rigors, generalized myalgias, and 
severe headache in most cases. Generally, HGA is a potentially life-threatening disease, 
and 36% of patients diagnosed with HGA require hospitalization, 7% need urgent care, 
and around 1% die [122]. The incidence of HGA has been increasing steadily, from 1.4 
cases per million (348 cases) in 2000 when it first became a reportable disease to the 
CDC reaching 6.1 cases per million (1761 cases) in 2010 [123]. Similar trends are 
evident in other countries in Europe and Asia [reviewed in [124]]. In addition, A. 
phagocytophilum strains that infect humans also affect a wide range of domestic and wild 
mammals from dogs, cats, and horses to different rodents [125].  Several factors 
including increases in Ixodes ticks densities, changes in human recreational practices, 
global warming, and abundance of wild hosts for the ticks result in higher risk of disease 
for humans as well as domestic animals [126].  Anaplasma phagocytophilum infects 
neutrophils, granulocytes and their progenitors, resulting in cytotoxic lymphocyte 
activation and overproduction of cytokines such as IFN-γ and IL-10, which negatively 
affects the immune system of its host [122,127]. The bacteria reside within granulocyte 
endosomes that fail to mature to phagosomes by preventing the fusion of lysosomes into 
the vacuole where it develops , thus avoiding destruction by the host [127]. 
A. phagocytophilum is transmitted by ticks of the Ixodes persulcutus complex, 
with I. scapularis and I. pacificus being the most important vectors in the USA [127]. 
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Transovarial transmission does not occur in these ticks, and has only been reported in tick 
species and A. phagocytophilum strains that are not implicated in the transmission cycle 
affecting humans and domestic animals [89]. The natural transmission cycle involves 
acquisition of the pathogen from small wild rodents by I. scapularis larvae, and 
transstadial transmission to nymphs and adults that may infect a mammalian host during 
a subsequent bloodmeal. Therefore, the ability of A. phagocytophilum to cycle between 
ticks and mammalian hosts is imperative for bacterial survival [89]. Survival in dissimilar 
hosts requires rapid adaptation of the bacterium to environments that present important 
physiological and other biological differences. This rapid adaptation to different 
environments most likely involves proteins and other molecules that are differentially 
expressed or produced during the infection of the tick vector and/or the mammalian host 
[54].  
A. phagocytophilum possesses a small genome of only 1.47 million bases pairs 
and 1,369 ORFs [128], which is why the organism needs to make efficient use of its 
genome in order to infect and survive in the mammalian host and its arthropod vector. 
This includes the expression of specific genes only during infection of a specific host cell 
type [54] or only at specific phases of infection [51,129]. Using a complete tiling array of 
the complete A. phagocytophilum genome, Nelson et al. [54] determined that 117  ORFs 
were differentially transcribed during infection of HL-60 cells, a promyelocytic leukemia 
cell line typically used to culture A. phagocytophilum, when compared to the expression 
in ISE6 cells, a tick cell line derived from I. scapularis embryos. Of these 117 ORFS, 76 
were upregulated during infection of HL-60 cells and 41 were upregulated in ISE6 cells 
[54]. Some of these upregulated genes have shown evidence of involvement in important 
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processes during infection of human and tick cells, such as adhesion to host cells and 
vacuole membrane formation [51,129,130]. However, a high percentage of the 
upregulated genes encode for hypothetical proteins (54% in HL-60 cells and 93% in ISE6 
cells) [54] and their role in the life cycle of A. phagocytophilum is still unknown. 
Proteome and transcriptome analysis of the proteins and genes expressed during the 
transmission of A. phagocytophilum from the salivary glands to mice also detected up to 
21 hypothetical proteins (15% of the detected proteins) that have not been characterized 
and several others that have been characterized during growth in HL-60 cells but their 
function in the tick vector remains unknown [97]. The high number of upregulated genes 
that encode proteins with unknown function highlights how little is known about the 
proteins involved in vector-pathogen interactions and about the pathogenesis of this 
organism.  
Functional genomics in A. phagocytophilum has focused on the study of gene 
expression and proteomics [97]. The identification of the proteins present during a 
specific phase of infection or during infection of a specific host is important in 
understanding the biology of the organism. However, it does not reveal the exact function 
and that these proteins fulfill. The intracellular nature of A. phagocytophilum, has made it 
difficult to study the function of genes involved in intracellular invasion and replication 
using genetic techniques such as site-directed mutagenesis via homologous 
recombination. Nevertheless, Felsheim et al. [54] developed a method for random 
mutagenesis of A. phagocytophilum using the Himar1 transposase system to transform A. 
phagocytophilum to express Green Fluorescent Protein (GFPuv) and a red fluorophore, 
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mCherry [131]. One of these tranformants has resulted in a gene knock-out that affects 
pathogenesis of A. phagocytophilum [10].  
Herein, I report the phenotypical changes that have resulted from two gene knock-
outs in two different mutants. One of these mutants presents an insertion in aph_0906 
that encodes a hypothetical protein. This gene is highly upregulated during infection of 
HL-60 cells[54], and in fact the mutation abrogates survival of A. phagocytophilum in 
these cells. A second transformant has an insertion into aph_0584, a member of the o-
methyltransferase family 3.  aph_0584 does not appear to be expressed during late phases 
of infection and transcripts are barely detectable in any of the host cells tested [54]. 
However, the mutant is unable to grow in tick (ISE6) cells, which indicates that the gene 
product facilitates some aspect of infection in tick cells. In this manuscript I 1) identify 
and describe the phenotype resulting from mutations in the APH_0906 and the 
APH_0584 genes with respect to infection of and growth in vitro and in vivo, 2) 
determine the expression pattern of these genes to identify the exact phase of infection in 
which they are important during infection of human and tick cells, 3) examine the 
presence of putative functional motifs in both proteins (APH_0906 and APH_0584) and 
the similarity of the protein products to other proteins with known function, and 4) 
establish the effects of a methyltransferase inhibitor on the entry and invasion of tick cells 
by A. phagocytophilum.  
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Materials and Methods 
 
Identification and growth of the mutant strains in ISE6 or HL-60 cells  
 Uninfected ISE6 cells were maintained in L-15C300 medium with an osmotic 
pressure of approximately 315 mOsm/liter [92], supplemented with 5 % fetal bovine 
serum (FBS), 5 % tryptose phosphate broth (TPB), and 0.1% lipoprotein concentrate 
(LPC). Fresh medium was supplied once a week and cultures were maintained at 34°C. 
The A. phagocytophilum isolate HGE2 was originally cultured from a human patient in 
Minnesota [92]. Several transformants were generated as described [54] to express Green 
Fluorescent Protein (GFPuv) or red fluorescent protein (mCherry). These transformants 
were generated in both HL-60 and ISE6 cells.  The ability of the transformants to growth 
in the reciprocal cell line in which they were produced (HL-60 to ISE6 or ISE6 to HL-60) 
was tested by inoculating purified cell-free bacterias as well as whole infected cells into 
25 cm2 flask containing the recipient cell line. The growth and development of the 
transformants in the reciprocal cell line was evaluated by fluorescent microscopy using 
an inverted Nikon Diaphot microscope (New York) and giemsa staining.  Two 
transformants were identified as having a defect in their ability to infect and survive 
within a different cell species from those in which it was originally produced. One of the 
transformants (designated as the APH0906-mutant), had a transposon insertion into 
aph_0906.  The APH0906-mutant was continuously grown in ISE6 cells as described in 
[54] by passing one tenth of infected culture onto an uninfected cell layer maintained in 
L-15C300 supplemented with 10 % FBS, 5 % TPB, and 0.1 % LC, and the pH was 
adjusted to 7.5 - 7.7 with sterile 1N NaOH (referred to herein as A. phagocytophilum 
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medium). Medium was changed twice a week. Medium was changed twice a week. 
Spectinomycin and streptomycin (100 μg/ml each) were added to the cultures for 
selection of mutants carrying the inserted aadA resistance gene, and cultures were 
monitored several times a week by fluorescence microscopy to detect A. 
phagocytophilum expressing green fluorescent protein GFPuv [79].  
 The second mutant was derived from the A. phagocytophilum isolate HZ, which 
was originally cultured from a New York patient [132], and had an insertion into the 
aph_0584 gene (designated as the OMT-mutant). The OMT-mutant was cultivated in 
HL-60 cells maintained in RPMI 1640 medium (Gibco, New York) supplemented with 
10% FBS and 2mM glutamine at 37°C with 5% CO2, in humidified air [92]. 
Spectinomycin (100 μg/ml) was added to the medium for selection of mutants. The 
bacteria were subcultured every 5 days by inoculating 3.2 x 103 infected HL-60 cells into 
a new flask containing around 3.6 x 105 uninfected cells and fresh medium. Uninfected 
HL-60 cells were maintained in the same medium and under conditions described for 
infected cells with the exception that antibiotics were not added. Cultures were monitored 
weekly for presence of A. phagocytophilum expressing GFPuv by epifluorescence 
microscopy using an inverted Nikon Diaphot (New York) with Sapphire GFP filters as 
described previously [21]. 
 
Determination of insertion sites 
 The number of insertion sites in each of the mutant populations was determined 
by Southern blots. DNA was purified from a 25 cm2 flask of HL-60 cells infected with 
the OMT-mutant and from a 25 cm2 flask of ISE6 cells infected with the APH0906-
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mutant, using the Puregene Core Kit A (Qiagen, Maryland). An extra phenol/chloroform 
extraction was performed to remove any remaining protein. The aqueous phase 
containing the nucleic acids was separated from the organic phase containing the proteins 
using tubes preloaded with Phase Lock Gel Heavy (5 Prime, Maryland). DNA 
concentration was measured with a BioPhotometer (Eppendorf, New York). Additionally, 
DNA was extracted from HZ and HGE2 wildtype bacteria. DNA (100 ηg) from the 
APH0906-mutant and wild type HGE2 were digested with BglII, HindIII and EcoRI. The 
same amounts of DNA from the OMT-mutant and wild-type HZ were digested with BglII 
and EcoRV. The samples were then electrophoresed in 1% agarose gels. DNA was 
transferred and probed as described in [79], using digoxigenin-labeled probes specific for 
GFPuv prepared with the PCR DIG Probe Synthesis kit (Roche, Indiana). The positive 
control consisted of 10 pg and 1 pg of the plasmid construct pHIMAR1-UV-SS originally 
used for the first A. phagocytophilum transformation [54].  
 To determine the insertion sites into each mutant population, 5 µg of DNA from 
the mutants was digested with BglII. Digested DNA from the HGE2 mutant was cleaned 
using a phenol/chloroform extraction as described above for the Southern blots, whereas 
the HZ mutant was cleaned with DNA clean & concentrator (Zymo Research, 
California). Cleaned DNA was ligated into the pMOD plasmid and then the construct was 
electroporated into ElectroMAX DH5α cells (Invitrogen, New York). Bacterial cells 
containing the transposon were selected on YT plates with 50 µg/ml of spectinomycin 
and streptomycin. DNA from transformed ElectroMAX DH5α cells was purified by 
phenol/chloroform extraction and then sequenced at the BioMedical Genomics Center 
(University of Minnesota).  
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Effects of the mutations on the growth of A. phagocytophilum as determined by qPCR 
 The APH0906-mutant and wild-type HGE2 were grown in 25 cm2 flasks 
containing ISE6 cells as described above. Bacteria of each isolate were purified from two 
flasks of infected ISE6 cells when infections reached >90%, and then separated from host 
cells by passing the cell suspension through a bent 27 Ga needle and filtration of the 
lysate through a 2 µm pore size filter. Purified bacteria were transferred into two 15 ml 
tubes and centrifuged at 2000 x g for 5 minutes and then resuspended in 3 ml of RPMI 
medium supplemented as described above. Five 25 cm2 flasks containing uninfected HL-
60 cells were inoculated with different dilutions of purified bacteria. The dilutions 
consisted of 0.5 ml of re-suspended bacteria in 20 ml of RPMI medium (1:40), 200 µl of 
re-suspended bacteria in 20 ml of RPMI medium (1:100) and 50 µl of re-suspended 
bacteria in 20 ml of RPMI medium (1:400). The experiment was repeated in triplicates. 
Inoculated cultures were incubated at 37°C as described above for infected HL-60 cells. 
Samples of 1.5 µl were taken from each dilution everyday for a 5 day period and DNA 
was extracted from each sample as described before for DNA samples used in Southern 
blots. The growth of the OMT-mutant in HL-60 cells was determined using the same 
procedure. 
To determine the growth curve of the APH0906-mutant in ISE6 cells, bacteria 
were purified as described for HL-60 cells but resuspended in L15C300 and inoculated 
into 12.5 cm2 flasks containing confluent cell layers of ISE6 cells. The dilutions used 
were: 0.5 ml of re-suspended bacteria in 2.5 ml of L15C300 medium (1:6), 0.25 ml of re-
suspended bacteria in 2.75 ml of L15C300 medium (1:12), and 125 µl of re-suspended 
bacteria in 2.875 ml of L15C300 medium (1:24). Four flasks were inoculated with each 
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dilution for each sampling day and the experiment was done in triplicate. The mutant 
bacteria grown in ISE6 cells were sampled every 3 days for 12 days by taking 1.5 ml of 
infected cells. DNA was extracted as described before. Likewise, the OMT-mutant was 
grown in HL-60 cells as described above. Bacteria were purified from four flasks 
containing 25 ml of an >90 % infected cell suspension.  Purified bacteria were divided 
into two 15 ml tubes and centrifuged at 2000 x g for 5 min. Supernatant was discarded 
and cell free bacteria were resuspended either in 3 ml of RPMI or L15C300. Bacteria 
were diluted and growth analyzed as described for the APH0906-mutant.  
 The number of bacteria per sample was determined by qPCR using the primers 
msp5 fwd and msp5 rev (Table 1) that amplify a fragment of the single copy number 
msp5 gene. qPCR reactions were performed in an Mx3005 pro (Agilent, California) 
cycler, using Brilliant II SYBR Green Low ROX QPCR Master Mix (Agilent, California) 
under the following conditions: an initial cycle of 10 minutes at 95°C, 40 cycles of 30 
seconds at 95°C, 1 minute at 50°C, and 1 minute at 72°C, and a final cycle of 1 minute at 
95°C, 30 seconds at 50°C, and 30 seconds at 95°C. A standard curve was developed 
using the msp5 fragment cloned into the pCR4-TOPO vector (Invitrogen, New York). 
 
Effect of the mutation on bacterial binding  
 OMT-mutant and wildtype A. phagocytophilum were purified from HL-60. Host 
cell-free bacteria purified from one fully infected 25 cm2 were added to about 2.5x105 
ISE6 cells in 50 µl of A. phagocytophilum medium in a 0.5 mL centrifuge tube. The 
bacteria were incubated with host cells for 30 min at room temperature, flicking the tube 
every 5 minutes to enhance contact between bacteria and cells. The cells were washed 
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twice with unsupplemented L15C300 and centrifuged at 300 x g for 5 minutes to remove 
unbound bacteria. The cell pellet was re-suspended in PBS and spun onto microscope 
slides for 5 minutes at 60 x g, using a Cytospin 4 (Thermo Shandon, Pennsylvania). 
Slides were fixed by submersion in methanol for 5 minutes and dried at 50°C for 10 
minutes. Bound bacteria were labeled using an indirect immuno-fluorescence assay (IFA) 
with dog polyclonal antibody against A. phagocytophilum and FITC-labeled anti-dog 
secondary antibodies. DAPI was used to stain the host cell DNA and aid in host cell 
visualization. The number of bacteria bound to 300 cells was counted for each sample. 
This was repeated in triplicate, and differences were evaluated using Student’s t-test to 
assess significance. A similar experiment was done with the APH0906-mutant.  HGE2 
wildtype and the APH0906-mutant were grown in ISE6 cells as described, and bacterial 
adhesion to uninfected HL-60 cells was determined as described for the OMT-mutant and 
ISE6 cells.  
 
Infection of hamsters with the APH0906-mutant and re-isolation from blood 
 Nine, 2-week old hamsters were injected intraperitoneally with 500 µl of ISE6 
cells infected with the APH0906-mutant. After 7 days, a tail blood smear stained-with 
Giemsa’s stain was examined microscopically to confirm infection. Additionally, two 
hamsters were euthanized by CO2 overexposure, and 800 µl of blood was removed by 
sterile heart puncture using a 25 Ga needle and syringe containing EDTA. 100 µl of 
blood was inoculated into HL-60 cell culture, 300 µl into ISE6 cell culture, and DNA was 
extracted from the remaining 400 µl. ISE6 and HL-60 cultures inoculated with the blood 
were maintained under the same conditions as described for cell cultures infected with 
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mutant strains, and monitored daily for bacterial growth using an inverted Nikon Diaphot 
(New York) fitted for fluorescence microscopy and a Sapphire GFP filter as described 
[133].  
 The seven remaining hamsters were kept for 21 days, and then blood was 
extracted after euthanasia as described above, using the Qiagen Puregene Core A kit 
blood protocol and treated with Proteinase K (Roche, Indiana) overnight at 50°C. DNA 
was subjected to a phenol/chloroform/isoamyl alcohol extraction to remove Proteinase K, 
using the Phase Lock Gel 2.0 tubes (5 Prime, Maryland). Nested primer pairs EE1-EE2 
and EE3-EE4 were used to PCR-amplify a 928 bp product by the first set of primers and 
a 867 bp product from A. phagocytophilum 16S rDNA by second as described [134] 
using FlexiTaq polymerase (Promega, Wisconsin). Amplified products were run in 
agarose gels and visualized using GelGreenTM (Biotium, California).  
 
Growth of APH0906-mutant in RF/6A and HMEC 
The ability of the APH0906-mutant to infect rhesus choroid-retina endothelial 
(RF/6A) cells and Human Microvascular Endothelial (HMEC-1, [135]) cells was tested. 
RF/6A cells were maintained in A. phagocytophilum medium (defined above) at 37°C 
with 5% CO2 in humidified air. HMEC-1 cells were maintained in RPMI medium as 
described for HL-60 cells. RF/6A and HMEC-1 cells were subcultured by trypsinization 
(Gibco, New York) as follow: cell layers were exposed to 1 ml of trypsin with EDTA for 
1 minute at 37°C, trypsin was aspirated, and cell layers incubated for an additional 4 
minutes at 37°C. Cells were resuspended in 5 ml of their respective growth medium, and 
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then diluted 10-fold in fresh growth medium. Both RF/6A and HMEC cells were 
subcultured every two weeks. 
The APH0906-mutant was grown in ISE6 cells as described above. When 
infection in ISE6 cell cultures reached >90%, the bacteria were purified from one 25 cm2 
flask and inoculated onto confluent RF/6A and HMEC-1 cell layers. Cultures were 
monitored weekly for presence of green fluorescent A. phagocytophilum by 
epifluorescence as stated above.  The levels of infection were monitored weekly for a 
month in three replicates by diluting 100 µl of trypsinized cell suspension in 900 µl PBS. 
Samples were spun onto microscope slides as described above fixed in methanol and 
stained with Giemsa’s stain (Gibco, New York). A total of 300 cells were counted and 
the number of infected cells was determined in each sample. 
 
Bioinformatics-based analysis of proteins encoded by genes identified in the mutants 
 The amino acid sequence of the hypothetical protein encoded by aph_0906 was 
analyzed using motif finder: MOTIF (http://www.genome.jp/tools/motif/), Motif Scan 
(http://myhits.isb-sib.ch/cgi-bin/motif_scan), and Pfam (http://pfam.sanger.ac.uk/search). 
PSI-BLAST was performed to exclude any members of the Anaplasmatacea family to 
find Position Specific Conserved Motifs that were present in proteins of unrelated 
organisms. To determine if specific regions of the protein presented high similarity to 
known motifs, regions of 300 amino acids were blasted separately. Additionally, the 
protein was analyzed to establish if putative DNA binding motifs were present within the 
complete protein sequence, using BindN (http://bioinfo.ggc.org/bindn/), GYM 2.0 
(http://users.cis.fiu.edu/~giri/bioinf/GYM2/welcome.html), and DNABindR 
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(http://turing.cs.iastate.edu/PredDNA/). To establish if a signal peptide was also present 
in the protein sequence, the prediction SignalP 4.0 
(http://www.cbs.dtu.dk/services/SignalP/) and PrediSi (http://www.predisi.de/) were 
used. Subcellular of the protein within the bacteria was assessed using the programs 
CELLO (http://cello.life.nctu.edu.tw/) and Psortb v3.0 
(http://www.psort.org/psortb/index.html).   
 To determine the origin of the A. phagocytophilum OMT, a protein sequence 
available in GenBank (gi|88607321) was used for a PSI-BLAST that excluded members 
of the Anaplasmataceae family. The OMTs identified as the most similar to the A. 
phagocytophilum OMT were aligned using ClustalW from MacVector 12.0 (MacVector, 
Inc, North Carolina). A Minimun Evolution phylogenetic tree of all the OMTs was 
generated using MEGA 4.0 [136]. To look for conserved motifs in similar OMTs, the 
protein sequences from the four closest, non-Anaplasmataceae OMTs along with the A. 
phagocytophilum OMT were input into MEME (http://meme.nbcr.net). Phyre2 
(http://www.sbg.bio.ic.ac.uk/~phyre2/html/page.cgi?id=index) was used to determine the 
putative tertiary structure and also to identify OMTs in other bacteria with a similar 
structure. 
 
Relative expression of APH_0906 and OMT 
 A. phagocytophilum HGE2 wild-type was purified from ISE6 cells and inoculated 
into four 25 cm2 flasks containing either uninfected ISE6 or HL-60 cells. Bacteria 
inoculated into ISE6 cultures were incubated at 34°C for 4, 24, 48, or 72 hours. Total 
RNA from bacteria and host was extracted from whole infected cell cultures, using the 
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Absolutely RNA Miniprep Kit (Agilent, California) according to the manufacturer’s 
specifications. Likewise, cell-free, wild-type A. phagocytophilum strain HZ was purified 
from HL-60 cells and inoculated into four 25 cm2 flasks containing either uninfected 
ISE6 or HL-60 cultures. Bacteria inoculated into HL-60 cells were incubated at 37°C for 
30, 60, 120, or 240 minutes and RNA was extracted as described above. RNA was 
DNAse treated with 0.5 units TURBO DNase (Ambion, New York), and incubated at 
37°C for 30 minutes. The DNAse treatment was repeated once.  RNA concentrations 
were measured using a Biophotometer as described for DNA.  
 Expression of aph_0906 was measured in extracts from the HGE2 strain and 
expression of the OMT was determined from HZ strain extracts. Gene expression was 
normalized against expression of the rpoB and msp5 genes that had been found to be 
significantly expressed in both cell types during tiling array analysis [54]. qRT-PCR 
reactions were carried out using Brilliant II QRT-PCR SYBR Green Low ROX Master 
Mix (Agilent, California) using primers for the omt, aph_0906, msp5, and rpoB described 
in Table 1. The reactions were run as follow: one cycle at 50°C for 30 min, one 
denaturing cycle at 95°C for 10 min, 40 cycles that consisted of 30 secs at 95°C, 1 min at 
50°C, and 1 min at 72°C, and a final cycle of 1 min at 95°C and 30 secs at 50°C.  Ct 
values were established during amplification and the dissociation curve was determined 
during the final denaturation cycle. Expression of the APH_0906 and the omt genes was 
analyzed using the 2-ΔΔct  method, and significant differences in expression of the genes 
were determined using Student’s t-test with SigmaStat (Systat Software, California).   
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Effects of the Inhibition of SAM dependent Methyltransferases on the binding of A. 
phagocytophilum to ISE6 cells 
 To confirm the effect of the omt mutation on binding, adenosine dialdehyde 
(adenosine periodate, or AdOx), which inhibits S-Adenosine Methionine (SAM) 
dependent methyltransferases by increasing the concentration of S-adenosyl-L-
homocysteine [114], was added to wild-type cultures  to abrogate o-methyltransferase 
activity. Wild-type and OMT-mutant bacteria were purified from 75 cm2 flasks 
containing infected HL-60 cells as previously described. Purified wild-type bacteria were 
incubated with AdOx at 20 ηM, 30 ηM, and 40 ηM final concentration for 1 hr at 34°C 
before adding them to 2x105 uninfected ISE6 cells. Controls consisted of wild-type and 
OMT-mutant bacteria purified the same way, but incubated at 34°C for 1 hr without 
addition AdOx.  
The bacteria and ISE6 cells were incubated in 200 µl of A. phagocytophilum 
medium at 34°C for an additional hr to allow binding. Cells were washed 3 times with A. 
phagocytophilum medium by centrifugation at 600 xg to remove unbound bacteria. After 
the final wash, cells were resuspended in 1 ml of A. phagocytophilum medium and 50 µl 
of the suspension was spun onto microscope slides using a Cytospin 4 centrifuge as 
described above. Cells were fixed in methanol for 10 min. The bacteria were incubated 
with dog anti A. phagocytophilum serum and labeled with FITC conjugated anti-dog 
antibodies. To aid in host cell visualization, nuclei were stained with DAPI. Bacteria 
were observed using a 100x oil immersion objective on a Nikon Eclipse E400 
microscope. Bacteria were counted as described above for regular binding assays, and 
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differences in the number of bacteria per cell were evaluated using the Student-Newman-
Keuls one-way ANOVA on ranks, using SigmaStat.   
 
Results 
 
Disruption of omt and aph_0906 genes results in phenotypic changes  
 Analysis of the phenotypic changes in A. phagocytophilum transformants was 
done by testing their ability to infect the reciprocal host-cell type in which they were 
propagated, e.g. transformants generated in ISE6 cells were tested in HL-60 cells and vice 
versa. Of several transformants, two were identified as unable to infect either ISE6 cells 
or HL-60 cells. The OMT-mutant, generated and maintained in HL-60 cells, was unable 
to infect and grow in ISE6 cells. In contrast, the APH0906-mutant was generated and 
maintained in ISE6 cells and was unable to grow in HL-60 cells. Both mutants express 
Green Fluorescent Protein (GFPuv) from a Himar1  transposon [54] and Southern blot 
analysis identified a single insertion site within each genome (Figure 1A and B). 
Digestion of omt-mutant DNA with EcoRV showed several smaller bands that are 
believed to be artifacts resulting from nonspecific digestion since digestion with BglII 
showed a single band, suggesting a clonal population (Figure 1B).  
 Recovery of the transposon along with flanking sequences from OMT-mutant 
DNA by restriction enzyme digestion and cloning indicated transposition into APH_0584 
(Gene ID: 3930223; o-methyltransferase 3 family member) occurred between nucleotide 
positions 612707 - 612706 of the HZ genome sequence ([128]; Figure 2A). The second 
mutant, obtained from the HGE2 isolate, resulted from transposition into the coding 
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region of the hypothetical protein gene aph_0906 (Gene ID: 3930051) at nucleotide 
positions 965962 – 965963 (Figure 2B) of the HZ genome (the HGE2 genome has not 
been sequenced). Several E. coli colonies from each mutant were examined and all 
revealed transposition into the same location, supporting a single insertion event. The 
single insertion event in both strains suggests that the changes in phenotype are due to the 
knockout of those particular genes. 
 
Mutation of the OMT and APH_0906 genes reduces A. phagocytophilum binding, 
growth, and survival 
 To determine the mechanisms by which the mutations affected the phenotype of 
A. phagocytophilum, I analyzed several parameters. I developed growth curves of the 
mutant strains in HL-60 and ISE6 cells using qPCR. The growth curves from the mutant 
strains were compared to the growth curves from wild-type bacteria grown under the 
same conditions. The APH0906-mutant persisted in HL-60 cells for up to 5 days post-
inoculation without a reduction in bacterial numbers (Figure 3A). This trend was 
observed in all three dilutions and was significantly different (P=0.004) from the growth 
of wild-type bacteria in HL-60 cells (Figure 3B), which showed a steady increase 
throughout the 5 days of the experiment. On the other hand, growth of the APH0906-
mutant in ISE6 cells was not impaired (Figure 3F) and was not statistically different 
(P=0.734) from the growth of wild-type HGE2 bacteria (Figure 3C), demonstrating that 
the mutation only affected the growth of the mutant in HL-60 cells. 
 By comparison, the OMT-mutant was not able to grow in ISE6 cells and msp5 
gene copy numbers decreased, resulting in a negative slope in its growth curve from all of 
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the dilutions tested (Figure 3D). Degradation of the bacteria occurred early during 
infection, starting at day 1 and continuing during the 12 days of the experiment. Gene 
copy numbers of the OMT-mutant were statistically different from those of wild-type 
bacteria in ISE6 cells (P=0.008). This is in contrast to their growth in HL-60 cells, in 
which the OMT-mutant bacteria are able to infect and multiply irrespective of the knock-
out of the gene. This was demonstrated by the positive slope in their growth curve when 
replicating in HL-60 cells (Figure 3E). When compared to wild-type bacteria grown in 
HL-60 cells (Figure 3B), the mutant did not present any significant difference in growth 
(P=0.504). 
 Because of the defects in growth for both of the mutants present at the first 24 hrs 
of incubation with the host cells, I tested the ability of the mutants to bind to ISE6 or HL-
60 cells during incubation for 30 min at 34°C or 37°C, depending on the host cell line. 
The OMT-mutant presented a significant reduction in binding (t-value= -4.1011; P= 
0.0001) to ISE6 cells from 0.3 bacteria per cell in the wild type to 0.12 mutant bacteria 
per cell (Figure 4A), which amounts to a >50 % reduction in binding. The APH0906-
mutant, on the other hand, did not present such a marked reduction in the binding, with 
an average of 0.8 bound bacteria per HL-60 cell compared to the wild-type, in which I 
observed 1.2 bacteria bound/cell (Figure 4B). This difference in binding represents ~30 
% reduction from the wild-type, which is statistically significant with a t-value of 3.901 
and P=0.008. Thus mutations had a negative effect on binding, however the omt knock-
out showed a stronger effect.  
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Development in HMEC and RF/6A cells is impaired, but the 0906-mutant is able to 
infect hamsters 
 Since the APH0906-mutant is unable to productively infect HL-60 cells, we tested 
its capacity to infect mammals. Inoculation of hamsters with the APH0906-mutant and 
amplification of an 867 bp fragment of A. phagocytophilum 16s rDNA from blood by 
nested PCR, demonstrated that 7 out of 9 hamsters (infection rate of 78 %) became 
infected, and 5 of them remained infected for 21 days  (Figure 5). Blood samples from 
mice injected with uninfected ISE6 cells did not show amplification of any product 
(negative control). Blood smears from Hamster 2 also contained morulae within 
neutrophils (data not shown). Additionally, two blood samples from PCR positive 
hamsters (Hamster 1 and 2) were inoculated into two different cultures of ISE6 cells and 
maintained under the same conditions as described for infected cells. After 5 weeks of 
incubation, only one culture was infected. The APH0906-mutant isolated from the 
hamster did not show any difference in development when compared to the mutant 
bacteria that were not passed through a rodent (data not shown). These results 
demonstrated the ability of the APH0906-mutant to infect rodents.  
To test if this mutant was able to infect human and non-human primate cells, 
HMEC-1 and RF/6A cells were inoculated with cell-free APH0906-mutant bacteria. The 
bacteria were able to bind to and probably enter into both cell types, as a large number of 
individual bacteria were observed attached to both RF/6A and HMEC cells (Figure 6A 
and E). However, the number of bacteria appeared to decrease with time as fewer bacteria 
were detected by day 6 (Figure 6B and F) and day 10 (Figure 6C and G). However, more 
bacteria were present in RF/6A cells (Figure 6B and C) than observed in HMEC cells 
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(Figure 6F and G) on both day 6 and 10, suggesting a more rapid decline in the human 
endothelial cells. Likewise, at day 14, more bacterial colonies were observed in RF/6A 
cells (Figure 6D) than in HMEC cells (Figure 6H). Nevertheless, the mutant colonies in 
both cell lines were very small and contained few individual bacteria when compared to 
the wild-type strain (data not shown).    
 
OMT gene (APH_0584) and APH_0906 are differentially expressed in ISE6 and HL-
60 cells 
Because of the OMT-mutant defects on infection during the first 24 hrs and the 
deficiency on binding detected after 30 min incubation with ISE6 cells, I tested the 
expression of the omt gene during early stages of A. phagocytophilum wild-type 
development in ISE6 cells. The results showed that at 30 min to 1 hr pi expression of the 
omt gene is not significantly upregulated in ISE6 (average 0.4 and 0.3 omt/rpoB ratio of 
expression, respectively) (Figure 7A). However, as infection of ISE6 cells progresses, 
OMT expression is upregulated and by 2 hours, the ratio of expression (omt/rpoB) 
reaches an average of 10.3 (Figure 7A), which corresponds to ~30 fold increase in the 
expression in ISE6 cells (Figure 7B). Subsequently it decreases to a 0.7 ratio of 
expression by 4 hr pi (Figure 7A), corresponding to only 1.2 fold upregulation in ISE6 
cells (Figure 7B). According to the statistical analysis, the differences in expression of 
the omt at 2 and 4 hrs were significant (P=0.01).  Two and four hours correspond to the 
time in which the bacteria are binding and entering into tick cells [92], which suggests the 
importance of methylation during the binding and internalization of A. phagocytophilum. 
By contrast, omt gene expression in HL-60 cells in which I measured ratios of expression 
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(omt/rpoB) at 0.2, 0.2, 0.4, and 0.4 at 30 min, 1 hr, 2 hr, and 4 hr, respectively (Figure 
7A), did not significantly change throughout the time points tested in this study. 
However, it is important to point out that even though the differences in ratios between 
HL-60 cells and ISE6 at 30 min and 1 hour was not statistically, there was still an 
upregulation in the gene at these time points as it is shown by the fold change of 3 and 4 
(Figure 7B). The steady increase in regulation and in the fold change probably represents 
the progression in the binding and interaction of the bacteria with ISE6 cells.  
Expression of aph_0906 in ISE6 vs HL-60 cells was compared as well. However, 
because of the results from the growth curve and binding assays which showed that the 
bacteria had a reduction in binding but were able to remain in the cells without 
replicating, early time points during the infection in HL-60 and ISE6 were not tested. 
Unlike the omt gene, the aph_0906 gene was shown to be expressed in both cell lines, but 
at different time points. At 4 hours pi, the expression ratio (aph_0906/rpoB) in ISE6 was 
0.15 whereas in HL-60 cells the ratio was 0.004 (Figure 7C). Expression of aph_0906 in 
ISE6 was reduced by 24 hr and remained low by 48 and 72 hr (ratios of 0.009, 0.032, and 
0.016 (aph_0906/rpoB), respectively) (Figure 7C), whereas it was upregulated in HL-60 
cells with ratios of 0.0009, 0.013, and 0.15 (aph_0906/rpoB) at 24, 48, and 72 hr pi 
(Figure 7C). These ratios represent fold changes of 0.03, 0.09, 0.38, and an increase in 
the fold change of 9.5 in HL-60 cells compared to ISE6 (Figure 7D), which demonstrates 
the upregulation of the gene at late time points.  
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In-silico characterization of APH_0906 and the OMT 
Analysis of the putative motifs present in the hypothetical protein APH_0906 
indicated the presence of several DNA binding residues in the translated protein sequence 
(Figure 8A). These residues were detected using BindN and DNABindR. The second half 
of the protein presented long stretches of amino acids with potential DNA binding 
properties starting around amino acid 1000 until the end of the protein at aa 1528 (Figure 
8A), specifically the sequence KPPRPARRGAKSSSAHSVAGV that was determined to 
have DNA binding properties by all 3 programs used (Figure 8B). Additionally, the first 
half of the protein contained a section of around 100 aa that showed high similarity (29 - 
33%) to members of the antirepressors BRO-N family, according to the BLAST results, 
with a high percentage of residues that represent a synonymous change as well (46 – 50% 
positive residues) (Figure 8C). Many of the conserved aa residues are predicted to be 
DNA binding residues (Figure 8B). Because of the presence of DNA binding motifs in 
the protein, we examined the APH_0906 protein sequence for the presence of putative 
signal peptides. However, neither SignalP 4.0 nor PrediSi detected signal peptides in the 
sequence (data not shown) and both localization prediction programs, CELLO and Psortb 
3.0v, suggested that APH_0906 is an outer membrane protein (Table 2).   
To try to understand the possible relationship of the A. phagocytophilum OMT 
with other members of this family of enzymes, PSI-BLAST was used to search for 
similar OMTs in other organisms. Among α-proteobacteria, only members of the family 
Anaplasmataceae and Candidatus Midichloria mitochondrii (order Rickettsiales) encoded 
OMTs with close relationship to A. phagocytophilum OMT (Figure 9A). Other OMTs 
that are closely related to A. phagocytophilum OMT occurred in the Δ-proteobacteria 
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(Figure 9A). Furthermore, when the motif sites were compared using MEME, the Δ-
proteobacteria OMTs appeared to be more similar to A. phagocytophilum OMT than the 
Candidatus Midichloria mitochondrii OMT (Figure 9B). Motif 1 presented 48% identity 
and 66% similarity to Haliangium ochraceum OMT, whereas C. M. mitochondrii OMT 
had 33% identity and 53% similarity. Motif 2 exhibited 60% identity and 74% similarity 
with Bdellovidrio bacteriovorus OMT compared to 52% and 67% with C.M. 
mitochondrii OMT, and Motif 3 showed 44% identity and 72% similarity to B. 
bacteriovorus OMT compared to 33% identity and 67% similarity with C. M. 
mitochondrii OMT (Figure 9B). These results corroborated the scores obtained with PSI-
BLAST (Table 3). The predicted secondary and tertiary structure of the protein presented 
high resemblance with other bacterial OMTs family 3 members, showing α-helices 
surrounding a complex of β-strands (Figure 9C) [110].  
 
Adenosine-peroxidase (AdOx) reduces the binding of wild-type bacteria 
  An inhibitor of SAM-dependent Methyltransferases was used to confirm the 
effects of methylation on binding to and infection of ISE6 cells by A. phagocytophilum. 
Wild-type bacteria were incubated with different concentrations (20 ηM, 30 ηM, and 40 
ηM) of adenosine periodate (AdOx) for 1 hour. Binding of AdOx pre-treated wildtype 
bacteria to ISE6 cells was evaluated after allowing bacteria to attach for 1 hour and was 
compared to untreated bacteria. All concentrations of AdOx affected the ability of A. 
phagocytophilum to bind to ISE6 cells significantly (P<0.001) (Figure 10A). In controls, 
an average of 0.529 bacteria bound per cell, compared to the OMT mutant with only 
0.156 bacteria per cell. 20 ηM Adox decreased binding to 0.307 bacteria per cell, which 
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was less than the reduction in attachment observed in the OMT mutant (Figure 10A and 
B). However, as the concentration of Adox increased to 30 ηM and 40 ηM, the effects 
were stronger than in the OMT mutant with only 0.093 and 0.086 bacteria bound per cell, 
respectively (Figure 10A and B). These results corroborate the effects that the inhibition 
of methylation had in A. phagocytophilum binding.  
Discussion 
In this manuscript, I report for the first time the effects of the mutations in specific 
genes on the ability of A. phagocytophilum to infect and grow in tick or mammalian host 
cells. Previously, Chen et al. [10] described an A. phagocytophilum mutant with an 
insertion in the dihydrolipoamide dehydrogenase 1 (lpda1) gene at the APH_0065 locus. 
This mutation affected the inflammatory response during infection of mice by increasing 
the production of reactive oxygen species from NADPH oxidase and NF-κB in vitro [10]. 
However, mutations with a direct effect on growth and infection in vitro have not been 
reported until now.  
The analysis of several mutants led to the discovery of two that had deficient 
growth in either ISE6 cells or HL-60 cells.  The first mutant had an insert into the 
APH_0584 gene which encodes an o-methyltransferase (OMT) family 3 (GI: 88598384). 
The knock-out of this gene diminished the ability of the bacteria to infect and replicate 
within ISE6 cells, but had no effect on the growth and infection of HL-60 cells or mice 
(data not shown). This suggested that the mutation affected a process required for 
invasion of tick cells. Analysis of the development of the mutant in ISE6 cells 
demonstrated a rapid decrease in bacterial numbers as early as 1 day pi (Figure 3D), 
which suggested an effect during early stages of infection. Indeed, the mutation reduced 
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the binding of A. phagocytophilum to ISE6 cells by over 50% compared to the wild-type 
bacteria. I considered that the lack of in methylation of a residue important for adhesion 
to and invasion of tick cells was responsible for the reduction in binding and 
internalization. This would explain the rapid decrease in bacterial numbers as A. 
phagocytophilum cannot survive extracellularly for long periods of time. To confirm that 
the decrease in binding is resulted from the defective methylation, an indirect inhibitor of 
methylation (Adox) was used to decrease the number of wild-type bacteria bound to ISE6 
cells 5-fold over the untreated control (Figure 10A). Even, in the lowest concentration of 
Adox reduced the binding of A. phagocytophilum to ISE6 cells by around 30%, 
suggesting that methyltransferases played a role in the binding process. Methylation 
proteins involved in the adhesion to host cells has been reported in other members of the 
Rickettsiales [115,137]. Methylation of Rickettsia prowazekii OmpB was shown to be 
important for adhesion to and infection of endothelial cells and for virulence [137], and 
involved two different lysine methyltransferases [115]. These authors discovered a 
mutation in a hypothetical methyltrasnferase gene in the Madrid E strain and that 
pathogenesis was restored in the R. prowazekii Evir (derived from Madrid E) after the 
methyltransferase was restored [138]. In V. vulnificus, mutation of a type IV leader 
peptidase/N-methyltransferase resulted in lower pathogenicity and its inability to adhere 
to epithelial cells in vitro [139]. There is evidence that methyltransferases play a role in 
viral infectivity as well.  Incubation of HIV-1 with Adox resulted in a reduction in viral 
infectivity, likely due to inhibition of methylation of one or more proteins [114], similar 
to the effect this methylation inhibitor had on binding of A. phagocytophilum to ISE6 
cells. 
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It is interesting that the search for OMTs similar to that encoded by aph_0584 of 
A. phagocytophilum only identified an OMT in one Rickettsiales organism outside the 
family Anaplasmataceae, i.e., in C. M. mitochondrii. C. M. mitochondrii is an 
intracellular organism that develops in the mitochondria of I. ricinus ticks, and is a 
member of a new family suggested to be most closely related to the Anaplasmataceae in 
the Rickettsiales [140]. No members of the OMT family 3 were found in any 
Rickettsiaceae, and the only enzyme to show slight similarities was a bifunctional 
methyltransferase (m7G46) present in some Rickettsia species, albeit with really high e-
values (0.28 – 1.2) (data not shown). This suggested that these OMTs family 3 members 
existing in Anaplasmataceae and the new family “Candidatus Midichloriaceae” are not 
required by other members of the Rickettsiales, or that their function is carried out by a 
different methyltransferase.  
Interestingly, the PSI-BLAST search assigned a better e-value (4e-40) to an OMT 
from the pathogen B. bacteriovorus than the e-value obtained for C. M. mitochondrii (2e-
36) OMT, suggesting that that the former enzyme is more similar to A. phagocytophilum 
OMT. Also, according to structural analyses, small molecule methyltransferases 
(SMMT), such as OMTs, posses N-terminal extensions, discrete domains and active sites 
that are critical for substrate binding and the positioning of the methyl accepting atom 
[110]. It is interesting to point out that motif 3, which correlates with the N- terminal of 
the A. phagocytophilum OMT, is involved in substrate binding in 900 OMTs from 
studied plants [110], and is more similar to the OMT from Δ-proteobacterium B. 
bacteriovorus than to that from C. M. mitochondrii. The higher similarities between B. 
bacteriovorus OMT and A. phacytophilum OMT were also apparent from the PSI-
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BLAST search results (Table 3). B. bacteriovorus is a predatory bacterium that attacks 
gram-negative bacteria and, like A. phagocytophilum, presents a biphasic life cycle with 
an “attack form” that attaches to the host cell and a “dividing form” that occurs only in 
the periplasm of its host [141] Like A. phagocytophilum, B. bacteriovorus develop in a 
compartment formed by host and bacterial proteins, but in the periplasm of the bacteria 
instead of the cytoplasm of cells, and differentially express genes depending on their 
environment [141,142].  B. bacteriovorus possesses an unknown binding protein that 
interacts with the outer membrane of its prey, and encodes two OMTs, one that is up-
regulated during growth phases and another during early phases of invasion [142]. Thus, 
it is possible that an ancestor of the families Anaplasmataceae and “Candidatus 
Midichloriaceae” obtained their OMTs from members of the Δ-proteobacteria.      
The second A. phagocytophilum mutant with a transposition event into the 
APH_0906 locus displayed a significant reduction in binding to HL-60 cells, and was 
unable to productively infect HL-60 cells. According to the growth curves, replication of 
the bacteria appeared to be arrested early during infection as bacterial numbers did not 
change during 5 days pi when >90% of the HL-60 cells in a culture became infected by 
wild-type bacteria [65]. Similarly, though the mutant was able to infect non-human 
primate RF/6A cells for up to 10 days, the number of bacteria did not significantly 
change within the 14 days of cultivation, suggesting impaired replication. Similar results 
were observed in the human endothelial cell line HMEC-1 in which fluorescent bacteria 
declined as observed by microscopy (Figure 5). However, the mutation of APH_0906 did 
not affect the ability of the bacteria to infect rodent hosts as mutants were able to infect 
and persist in 78 % of the hamsters infected in this study.  It would be interesting to 
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analyze the immune response of the host to observe the potential use of the mutant as a 
vaccine strain.  
Bioinformatic analysis of the hypothetical protein encoded by APH_0906 
identified putative DNA binding sites within several parts of the sequence. A BLAST 
search revealed similarities of the first half of the protein with BRO-like protein domains 
from Lactobacillus phage Lv-1 and BRO Enterococcus faecium Com15 (YP_002455816 
and ZP_05678756, respectively). BRO-proteins are also found in Bombyx mori 
nucleopolyhedrovirus that infect insects in the order Lepidoptera as well as in several 
other dsDNA viruses of insects [143] and in bacteriophages and transposable elements in 
bacteria [144]. In infected cells, BRO-proteins are exported into the nucleus and the 
cytoplasm [143]. The first 100 – 150 aa in the N-terminus of the BRO-like proteins are 
conserved and have been shown to bind nucleic acids. Related coding sequences have 
been found in viruses, bacteriophages or prophages integrated into bacterial genomes, 
including that of Yersinia pestis [144]. This region and the region from amino acids 120 – 
220 in the protein sequence of APH_0906 show high similarity. According to our PSI-
BLAST search results, the only other proteins with similarity to APH_0906 are 
hypothetical proteins with unknown function in A. central and A. marginale. Because of 
this, hypotheses of the potential function of APH_0906 are difficult and more studies are 
necessary. 
This manuscript represents the first report of random mutagenesis of two A. 
phagocytophilum genes to which we were able to assign a role in the infection process of 
tick or mammalian host cells based on their mutant phenotype. Although the exact 
function of both proteins remain to be elucidated, evidence presented here identifies 
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APH_0584 as a member of the o-methyltransferase family 3 that methylates A. 
phagocytophilum MSP4 and possibly other targets, and APH_0906 as a putative DNA-
binding protein with evidence that it may be secreted, and transported into the nucleus or 
cytoplasm to modulate host responses. Biochemical and mechanistic studies to determine 
their exact function will be the focus of future studies.  
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Figure and Tables  
Table 1. Primers used for qPRC or qRT-PCR to quantify genes or expression of genes of the pathogen A. phagocytophilum 
 
Gene target Primer identifier Sequence Piece size  
Major Surface Protein 5 (Msp5) Msp5 fw 
Msp5 rev 
5’-GCTTATGTTCGGCTTTTCTTC-3’ 
5’-CCTTCACTATCAGATTCACCTACG- 3’ 
320 bp 
RNA polymerase subunit B (rpoB) rpoB fw 
rpoB rev 
5’-CTTTATCCTGCTTTAGAACAACATC-3’ 
5’-GGTCCGTATGGTCTGGTTACTC-3’ 
286 bp 
 
o-methyltransferase family 3 (omt) Omt fw 
Omt rev 
5’-CAGTTGGGTGCTCATCAAATAC-3’ 
5’-GCAAACAAATCCTCATACCTTG-3’ 
121 bp 
 
APH_0906 Aph_0906 fw 
Aph_0906 rev 
5’-AGCTCATATGCACAACTATG-3’ 
5’-AAACGGACACTCTCTATGTT-3’ 
247 bp 
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Figure 1. Southern blots showing the insertion events within the OMT and APH_0906 
mutants.  
 A) The APH0906-mutant digested with BglII, EcorRI, and HindIII presented a single 
band (as shown by white arrows) when labeled with UVSS probe that binds to GFPuv gene 
sequence. Wildtype HGE2, also digested with same enzymes, did not show any band, ruling out 
the possibility of nonspecific binding. B) The OMT-mutant was digested using BglII and EcoRV. 
EcoRV digestion of the mutant presents several lighter bands, however these are probably 
artifacts from the digestion since BglII digestion presents a single band. Wild-type HZ DNA 
digested with BglII was used as negative control. Bands representing real insertion events are 
indicated with black arrows.  
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Figure  2. Insertion sites in A. phagocytophilum mutant strains that present phenotypic 
changes.  
A) Insertion site of the construct containing the GFPuv protein gene (light green), 
Spectinomycin resistance gene (blue), and the Am tr promoter (red) within the himar repeats 
(dark red). The coding region of the O-methyltransferase family member 3 gene aph_0584 
(dark yellow) was interrupted at positions 612707 – 612706. B) Insertion site of the construct 
containing the GFPuv protein gene (dark green), Spectinomycin resistance gene (blue), and the 
Am tr promoter (red) within the himar repeats (dark red). The coding region of the hypothetical 
protein APH_0906 (light green) was interrupted at positions 965962 – 965963. 
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Figure  3. Effects of the mutation on the growth of A. phagocytophilum during infection of 
tick and human cells. 
       Growth curves representing the development of (A) the APH0906-mutant in HL-60 cells, 
(B) wild-type HZbacteria in HL-60 cells, (C) wild-type HGE2 in ISE6 cells, (D) the OMT-
mutant in ISE6 cells, (E) the OMT-mutant in HL-60 cells, and (F) the APH0906-mutant in ISE6 
cells. Each point in the graph represents the average number of bacteria from triplicates. Each 
line color corresponds to the dilution used to inoculate the uninfected cells. Red stands for the 
dilution 1:6 (ISE6 cells) or 1:40 (HL-60 cells), green represents the dilutions 1:12 (ISE6 cells) or 
1:100 (HL-60), and purple stands for 1:24 (ISE6 cells) or 1:400 (HL-60 cells). The linear bars in 
each time point represent the standard error. The Y axis is shown in Log2 to represent growth.  
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Figure  4. Reduction in the binding of A. phagocytophilum mutant strains to tick or human 
cells. 
A) Average of the HZ bacteria bound per ISE6 cell. Red bar represents the average OMT-
mutant bacteria bound to ISE6 cells, whereas the yellow bar represents the average of wildtype 
HZ bacteria bound. B) Average of the HGE2 bacteria bound per HL-60 cell. Red bar represents 
the average APH0906-mutant bacteria bound to HL-60 cells, whereas the yellow bar represents 
the average of wild type HGE2 bacteria bound. The lines above each bar represent the standard 
error. 
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Figure  5. Experimental infection of hamsters with the APH0906-mutant 
 Negative control consisted of blood from hamsters injected with uninfected ISE6 cells 
(lanes A), positive control consisted of DNA from APH0906-mutant grown in ISE6 cells (lanes 
B), lanes 1 – 9 represent the PCR products from each of blood sample taken from the nine 
inoculated hamsters. Lanes 1 and 2 show the products from the blood samples taken after the 
first week of infection. The remaining lanes, 3 – 9, show the products from blood samples taken 
21 days p.i. The 100 bp ladder (New England Biolabs, Massachusetts) is shown in the first lane 
of each gel. Molecular markers from 500 bp and 900 bp are indicated by the arrows.  
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Figure 6. Development of the APH0906-mutant in RF/6A and HMEC cells 
 Fluorescence microscopy with UV light and Sapphire filter images of the APH0906-
mutant during infection of RF/6A cells at day 3 (A) and day 10 (B). C) Cytospin showing a 
Giemsa staining preparation of RF/6A cells infected with the APH0906-mutant at day 14. 
Fluorescence microscopy with UV light and Sapphire filter images of the APH0906-mutant 
during infection of HMEC cells at day 3 (D) and day 10 (E). F) Cytospin showing a Giemsa 
staining preparation of HMEC cells infected with the 0906-mutant at day 14. APH0906-mutant 
in fluorescent microscopy images is shown by yellow arrows and by black arrows in Giemsa 
stain images. 
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Figure 7. Differential expression of the omt gene and aph_0906 during infection of ISE6 and 
HL-60 cells.  
 A) Expression of the omt gene during infection of ISE6 and HL-60 cells. Red bars 
represent the expression of the omt gene during A. phagocytophilum HZ wildtype infection of 
ISE6 cells, whereas yellow bars represent the expression of the omt gene during infection of this 
same strain in HL-60 cells. B) Fold change in the expression of the omt gene comparing 
ISE6/HL-60. The bars represent the average of the fold change and the lines represent the 
standard errors. C) Expression of aph_0906 gene during infection of ISE6 and HL-60 cells. Like 
in graph A, red bars represent the expression of A. phagocytophilum in ISE6, whereas yellow 
represents the expression in HL-60 cells; using HGE2 wildtype bacteria. The length of the solid 
bars represents the average expression and the lines above the bars represent the standard error of 
each time point. D) Fold change in the expression of the aph_0906 gene comparing HL-60/ISE6. 
The bars represent the average of the fold change and the lines represent the standard errors. 
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Figure 8. Putative DNA binding residues detected in the protein APH_0906.  
 A) Linear representation of the amino acid sequence of APH_0906 showing all the 
putative residues detected. The black bar symbolizes the complete amino acid sequences of 
APH_0906, positions in the sequence are shown by the red numbers. The pink bars show the 
localization of DNA binding residues detected using BindN and DNABindR. The blue line 
represents the position of the DNA motif detected by GYM 2.0. The red line represents the 
position the residues that presented high similarity with BRO motif of the antirepressor protein 
from the Lactobacillus phage LV-1 detected by PSI-BLAST. B) Amino acid sequence of 
APH_0906 showing specific residues that present putative DNA binding capabilities. The 
residues marked with red asterisks were detected using BindN and DNABindR, all other amino 
acids indicated by the pink bars were detected by one of the program as putative binding 
residues.  C) NCBI representation of the antirepressor protein from Lactobacillus phage LV-1. 
The blue bar represents the BRO domain in the protein and the blue line indicates the residues 
that show high similary and percentage of positives with APH_0906. The exact function of BRO 
proteins is unknown, however it is suggested they are DNA binding proteins that influence host 
DNA replication and transcription. 
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Table 2. Results from the predicted localization of the APH_0906 protein in A. phagocytophilum 
CELLO PSORTb 3.0v 
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Figure 9. Similarities between the A. phagocytophilum OMT to the enzymes present in 
other bacteria  
 A) Phylogenetic tree generated with the amino acid sequence of the 30 enzymes 
most similar to the A. phagocytophilum OMT. The relationship between the OMTs was 
inferred using the Minimum Evolution method. The bootstrap values from1000 replicates 
are shown next to the branches. The evolutionary distances were computed using the total 
number of differences. All positions containing gaps and missing data were eliminated 
from the dataset (Complete deletion option). Members of the Anaplasmatacaea family are 
shown in maroon, members of the α-proteobacteria are shown in red, Δ-proteobacteria 
are shown in green, Cyanobacteria are shown in light blue, Actinobacteria are shown in 
pink, Bacteriodetes are shown in dark purple, Chloroflexi are shown in medium blue, 
Acidobacteria are shown in dark green, Firmicutes are shown in light purple, and γ-
proteobacteria are shown in dark blue. B) Alignment of the amino acid sequences from 
the 5 non-Anaplasmatacaea members closest related to the A. phagocytophilum OMT. 
Motifs found using MEME are represented by the blocks on the alignments. The 
conserved residues on the motif sequences from each of the OMT sequences are shown in 
the alignment. C) A. phagocytophilum OMT putative tertiary structure as predicted by 
Phyre2. The C and N-terminus are shown by the arrows.   
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Table 3. Protein identity of the subjects with the highest identity and similitude to A. 
phagocytophilum retrieved with PSI-BLAST 
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Figure 10. Repression of SAM-dependent methyltransferases before inoculation results 
in a reduction of binding to ISE6 cells that is concentration dependent 
 A) Bars represent the average number of bacteria bound to ISE6 cells in each 
treatment. The lines above the bars show the standard error from four replicates. B) 
Images of the bacteria bound to ISE6 cells in the different treatments. Bacteria were 
labeled with FITC (green fluorescence) while the DNA was labeled with DAPI (blue 
fluorescence) to count the number of host cells. The yellow arrows point to bacteria that 
are not bound to ISE6 cells, whereas the white arrows show the bacteria that are attached 
to cells. 
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Chapter 3 
 
 
 
Methylation of an Anaplasma phagocytophilum outer membrane protein is required for 
adhesion to tick cells 
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Introduction 
 
Methyltransferases are involved in important bacterial activities such as cell 
signaling, cell invasion, and gene expression, as well as in metabolic pathways and 
pathogenesis [110,117,145]. They participate in the modification of membrane 
components, cofactors, signaling and defense compounds [110] and have been linked 
with virulence of several bacteria [139,146,147], fungi [148], and viruses [114]. 
Methyltransferases have been proposed to be important virulence factors conserved 
among several bacterial taxa [139,149,150], and methylation of outer membrane proteins 
and other membrane components has been shown to be an essential part of invasion and 
pathogenesis in several pathogens, including bacteria and viruses [114,115,117,139,148]. 
For example, inhibition of methyltransferases reduced the ability of HIV-1 to infect and 
replicate within CEMT- and HEK293T cells transfected with the HIV-1 proviral plasmid 
pNL4,  [114], possibly by inhibiting virus binding and cell entry. Transfected HEK293T 
cells produce pseudoviruses and are used to study envelope proteins and molecules 
important for the study of  invasion and infection process of HIV- viruses [151]. 
According to Willensen et al. [114], AdOx affected the methylation of the envelope 
proteins (Env), which reduced the ability of the virus and pseudovirus to enter host cells. 
Likewise, it has been shown that methylation of the outer membrane protein B (OmpB) is 
necessary for binding to and invasion of endothelial cells by Rickettsia prowazekii, the 
etiologic agent of epidemic typhus. Bacteria with a frame shift or other mutation in a 
lysine methyltransferase (rRP027-028) gene are attenuated and have been used as a 
vaccine strain previously [146]. Likewise, the methylation of glutamic acid residues in 
the outer membrane protein OmpL32 of  Leptospira interrogants has been suggested to 
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be involved in the virulence of the pathogen and its ability to colonize kidney cells in 
hamsters [118].  
O-methyltransferases (OMTs) affect the virulence of pathogens from bacteria to 
fungi [148,152], e.g., through modification of the outer membrane components or toxins. 
OMTs have been proposed to be virulence factors in pathogenic strains of 
Mycobacterium sp., Francisella sp., Legionella sp., and in Coxiella burnetii in which 
they are highly conserved, but are less related to those from non-pathogenic strains [117]. 
Moreover, the enzymes appear to be closely related to the OMTs present in their hosts 
[117]. Mutation of a 3-o-methyltransferase gene in Mycobacterium avium prevented the 
methylation of glycopeptidolipids that form part of the surface of the bacteria, resulting in 
the loss of pathogenicity for mice and immune clearance [152]. Nodulation of 
Rhizobium sp. and specificity of the bacteria for certain host plants is regulated by Nod 
factors that are modified by an o-methyltransferase [153]. Likewise, the mutation of an o-
methyltransferase gene, Aph_0584,  in the rickettsial pathogen Anaplasma 
phagocytophilum has negative effects on the binding of this bacterium to the tick 
embryonic cell line ISE6, derived from Ixodes scapularis.  
A. phagocytophilum is a tick-borne pathogen that causes Human Granulocytic 
Anaplasmosis (HGA), a disease that has been gaining importance in the USA and Europe 
[154], and is expanding into areas where the pathogen was not present before [154-156]. 
It is carried and transmitted by ticks of the I. ricinus group [157], although the pathogen 
has been found in several other ticks, including species in the genera Amblyomma, 
Dermacentor, and Haemaphysalis, but which have not been shown to be vectors  [as 
reviewed in [158]]. Likewise, this pathogen infects several mammalian hosts including 
75 
 
 
 
ruminants, rodents, wolves, dogs, cats, horses, and humans [as reviewed in [158]]. It 
develops in neutrophil granulocytes, neutrophil progenitor cells and less frequently 
eosinophils, and possibly in endothelial cells [85].  
The development of A. phagocytophilum in Ixodes sp. vector ticks remains 
unknown but has been described in tick cell culture where it is biphasic [92]. A. 
phagocytophilum development in ISE6 cells is very different from that observed in HL-
60 and endothelial cells [92], and although many of the molecular events involved in the 
infection of mammalian cells are known [159], little is known in the tick counterpart. 
Studies to understand vector-pathogen interactions have focused on the tick responses 
and tick factors important for the infection process of the pathogen in ticks [160-162], but 
little is known about which A. phagocytophilum genes and proteins are important for 
development in tick cells and ticks. Some studies have looked at the specific gene 
expression of  A. phagocytophilum during infection of I. scapularis ticks or ISE6 cells, 
but have focused on certain periods, such as transmission feeding or late phases of 
infection [54,97]. As a result, little is known about what proteins and their modifications 
are necessary for the early phases in successful infection of tick vector cells by A. 
phagocytophilum. Here, I report on methylation of the Major Surface Protein 4 (Msp4) 
and the possible role that this modification plays in the bacterium’s ability to bind to and 
infect ISE6 cells. 
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Materials and Methods 
 
Recombinant OMT (rOMT) protein was produced using the pET29a expression 
vector (Novagen, Germany) by amplifying the entire coding region with the primers 
rOMT fw and rOMT rv (Table 1). The product was amplified using pfu DNA polymerase 
(Promega, Madison, WI), under the following conditions: one denaturating cycle at 94 °C 
for 3 min, 10 cycles with a denaturating step at 94 °C for 1 min, 40 °C for 1 min for 
annealing, and extension at 72 °C for 2 min, then 20 additional cycles with a denaturating 
step at 94 °C for 1 min, 47 °C for 1 min for annealing, and extension at 72 °C for 2 min, 
and a final extension step of 5 min at 72 °C. The amplified product was then digested 
with the restriction enzymes SalI and EcorV, followed by the ligation into the vector at 
15°C overnight. The plasmid was cloned into One Shot® TOP10 competent cells 
(Invitrogen, Grand Island, NY) for replication. Plasmid was purified using the High Pure 
plasmid isolation kit (Roche, Indianapolis, IN).  Integrity of the plasmid was checked by 
sequencing the plasmid with the T7 promoter (5’- TAA TAC GAC TCA CTA TAG GG 
– 3’) and the T7 terminator (5’- GCT AGT TAT TGC TCA GCG G – 3’) primers at the 
Biomedical Genomics Center of the University of Minnesota. Sequences were reviewed 
using MacVector 12.5 (MacVector, Inc., Cary, NC) and when the integrity was 
confirmed, plasmids were transfected into BL21(D3) E. coli (New England Biolabs, 
Ipswich, MA) for expression. BL21(D3) E. coli were inoculated into 100 ml of Superior 
Broth (AthenaES, Baltimore, MD), induced with 200 µM IPTG, and incubated at 37°C 
overnight with constant shaking. Protein was purified using Ni-NTA Fast Start Kit 
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columns (Qiagen, Germantown, MD). Protein concentrations were measured using the 
BCA protein assay kit (Pierce, Rockford, IL).   
Functional rOMT was produced using the expression vector pET29a and the 
procedure described previously but amplifying the full coding region of the gene with the 
primers rOMTns Fw and rOMTns Rv (Table 1), using the following conditions: one 
denaturating cycle at 94 °C for 3 min, 10 cycles with a denaturating step at 94 °C for 1 
min,  45°C for 1 min for annealing, and extension at 72 °C for 2 min, then 20 additional 
cycles with a denaturating step at 94 °C for 1 min, 54 °C for 1 min for annealing, and 
extension at 72 °C for 2 min, and a final extension step of 5 min at 72 °C. The amplified 
product was then digested with NdeI and EcoR1, and then ligated into pET29a to produce 
rOMTns to eliminate the S-tag present in the plasmid. Ligated pET29- rOMTns plasmid 
was then cloned into One Shot® TOP10 competent cells, integrity of the plasmid was 
determined as previously described. The plasmid was cloned into Rosetta 2(DE3) pLysS 
(Novagen, Germany) cells. Transformed E. coli were incubated in 100 ml of superior 
broth and induced with 1 mM IPTG at 37 °C for 5 hours. Proteins were purified with Ni-
NTA Fast Start Kit columns as previously described, and protein concentration was 
measured as described previously.   
 
Serum production  
 Recombinant non-functional rOMT was dialyzed in a 3 ml Slide-A-Lyzer 
Dialysis Cassette 10K MWCO (Thermo Scientific, Rockford, IL) and tris-buffered saline 
(TBS), changing the TBS after two hours and dialyzing in fresh TBS overnight. Four 6 – 
8 weeks old C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) were immunized by 
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injection of 100 µg of the recombinant non-functional dialyzed rOMT in 50 µl elution 
buffer combined with an equal volume of TiterMax Research adjuvant (CytRx Co., 
Norcross, GA). The vaccine was divided into 100 µl doses given subcutaneously (s.c.) on 
the back at the base of the tail. Mice were given a second and third booster injection with 
100 µg of the rOMT 14 days and 24 days later, respectively. Blood was collected 10 days 
after the third booster by heart puncture after euthanasia using CO2 overexposure. Mice 
from the same cohort, but that were not immunized with the recombinant protein, were 
used as controls. Serum was prepared by incubating the blood at 37 °C for 60 min. After 
incubation, the clot that formed was separated from the walls of the centrifuge tubes 
followed by an overnight incubation at 4 °C. The tubes containing the samples were 
centrifuged at 3000 RPM for 10 min and serum was collected from tubes and frozen at -
20°C. 
 
Localization assays 
Wild-type bacteria from the isolate HZ (HZWT) were grown in 75 mL flasks 
containing HL-60 cells until >90% of the cells were infected. Around 5 x 107 infected 
cells were used to obtain cell free bacteria by vortexing the infected cells with 60/90 grit 
silicon carbide (Lortone, inc., Mukilteo, WA) for 30 seconds followed by filtration 
through a 2.0 μm pore size filter and centrifugation at 700 x g for 5 min to remove 
remaining cell debris.  The percent of infected cells in the culture was calculated by 
counting the number of infected and uninfected cells in two different Giemsa-stained 
preparations from the same flask that had been centrifuged onto slides using a Cytospin 4 
centrifuge (Thermo Shandon, Asheville, NC) for 5 min at 1,000 xg. The total number of 
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cells was determined by counting using a hematocytometer. Cell free bacteria were co-
cultivated with 2.5 x 105 uninfected ISE6 cells in 500 µl of A. phagocytophilum medium 
(described in Chapter 2) and incubated for 2 hours at 34°C to allow binding and 
expression of the OMT. Unbound bacteria was removed with three washes using A. 
phagocytophilum medium and centrifugation at 800 x g to collect only those bacteria 
bound to tick cells. Resuspended whole cell samples (100 µl) were taken and diluted into 
900 µl of fresh medium. Samples were spun onto a microscope slide at 1000 rpm for 5 
min using a Cytospin 4 centrifuge.  
Cell spots were fixed for 10 min in methanol, and incubated with anti-rOMT 
serum diluted 1:250 in phosphate-buffered saline (PBS) containing 3 % bovine serum 
albumin (BSA) for 2.5 hours at room temperature. The slides were washed 3 times in 
PBS and blocked in PBS with 3% BSA for 10 min at room temperature. OMT expressing 
bacteria were then labeled with anti-mouse antibodies conjugated with TRITC (1:500 
dilutions) for 1 hour at room temperature. All A. phagocytophilum were labeled with anti- 
A. phagocytophilum dog serum diluted 1:500 followed by incubation with anti-dog IgG 
conjugated to FITC for contrast, using the same procedure. Tick cell nuclei were labeled 
using DAPI present in the VectaShield mounting medium (Vector laboratories, 
Burlingame, CA) and samples were viewed with a Nikon Eclipse E400 microscope 
(Nikon Instruments, Melville, NY). Images were recorded with a Nikon digital camera 
DXM1200 (Nikon Inc., Melville, NY ), using Nikon ACT-1 software.  
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Measurement of the differential expression of proteins and determination of 
methylation 
HZ wild-type bacteria and OMT-mutant HZ bacteria were grown in two 250 ml 
flask containing 50 ml of RPMI medium with HL-60 cells each. The number of infected 
cells was determined as previously described. Cell free bacteria, mutant and wildtype, 
purified from 2.5 x109 infected cells that were ruptured by repeated passage through a 
27G needle and centrifuged at 600 x g to remove cell debris, were inoculated into an 
entire 25 cm2 flask containing 6.4 x 107 cells. Needle purification was used to avoid 
introducing small silicone particles in the MS/MS apparatus that could result in damage. 
This procedure was replicated three times. Cells and bacteria were incubated for 4 hours 
at 34 °C without agitation and bacteria were purified from ISE6 cells as described above, 
using the needle and syringe to rupture cells. Bacteria were washed in un-supplemented 
L15Cd medium three times by centrifugation at 16,000 xg for 5 min at 4 oC to remove 
FBS, and the final bacteria pellet was extracted for mass spectrometry.   
 
Protein Extraction and Preparation* 
 
 Protein concentrations were determined by Bradford assay using two aliquots for 
each sample. All samples were prepared as follows at the Center for Mass Spectrometry 
and Proteomics at the University of Minnesota: cell pellets were reconstituted with 120 µl 
of protein extraction buffer [7 M urea, 2 M thiourea, 0.4 M triethylammonium 
bicarbonate (TEAB) pH 8.5, 20% methanol and 4 mM tris(2-carboxyethyl)phosphine 
(TCEP)] while on ice.  Samples were sonicated at 30% amplitude for 7 seconds with a 
Branson Digital Sonifier 250 (Emerson, Danbury, CT). The sample was transferred to a 
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PCT tube, which is a shredder used to homogenize protein samples, with a 50 µl cap for 
the Barocycler NEP2320 (Pressure Biosciences, Inc., South Easton, MA) and cycled 
between 35k psi for 30 sec. and 0 k psi for 15 sec. for 40 cycles at 37 °C.  The PCT tube 
was uncapped and 200 mM methyl methanethiosulfonate (MMTS) was added to a final 
concentration of 8 mM MMTS, recapped, inverted several times and incubated 15 min at 
room temperature.  The sample was transferred to a new 1.5 ml Eppendorf LoBind 
Protein microcentrifuge tube (Eppendorf, New York, NY).       
In-solution proteolytic digestions were performed as follow: a 200 µg aliquot of 
each sample was transferred to a new 1.5 ml microfuge tube and brought to the same 
volume with protein extraction buffer plus 8 mM MMTS.  All samples were diluted four 
fold with ultra-pure water and trypsin (Promega, Madison, WI) was added at a 1:35 ratio 
of trypsin to total protein.  Samples were incubated for 16 hr at 37 °C after which they 
were frozen at -80 °C for 30 min and dried in a vacuum centrifuge.  Each sample was 
then cleaned using a 4 ml Extract Clean™ C18 SPE cartridge (Grace-Davidson, 
Deerfield, IL), and eluates were vacuum dried  and resuspended in dissolution buffer 
(0.5M triethylammonium bicarbonate, pH8.5)  to a final 2 µg/µl concentration. For each 
iTRAQ® 4-plex (AB Sciex, Foster City, CA), two 50 µg replicates for each sample were 
labeled with iTRAQ® reagent (AB Sciex). After labeling, the samples were multiplexed 
together and vacuum-dried.  The multiplexed sample was cleaned with a 4 mL Extract 
Clean™ C18 SPE cartridge (Mandel Scientific Company Inc., Guelph, Canada) and the 
eluate was dried in vacuo.  
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Peptide Liquid Chromatography Fractionation & Mass Spectrometry*  
 
The iTRAQ® labeled samples were resuspended in Buffer A (10 mM ammonium 
formate pH 10 in 98:2 water:acetonitrile) and fractionated offline by high pH C18 
reversed-phase (RP) chromatography [163]. A MAGIC 2002 HPLC (Michrom 
BioResources, Inc., Auburn, CA) was used with a C18 Gemini-NX column, 150 mm x 2 
mm internal diameter, 5 µm particle, 110 Å pore size (Phenomenex, Torrence, CA).  
Buffer A was 10 mM ammonium formate, pH 10 in 98:2 water:acetonitrile  and Buffer B 
was 10 mM ammonium formate, pH 10 in 10:90 water:acetonitrile. The flow rate was 
150 µl/min with a gradient from 5-35% Buffer B over 60 min, followed by 35-60% over 
5 min.  Fractions were collected every 2 min and uv absorbances were monitored at 215 
nm and 280 nm.  Peptide containing fractions were divided into two equal numbered 
groups, labeled “early” and “late”.  The first “early” fraction was concatenated with the 
first “late” fraction by combining the two fractions, and so on.  Concatenated samples 
were dried in vacuo, resuspended in load solvent (98:2:0.01, water:acetonitrile:formic 
acid) and 1-1.5 µg aliquots were run on a Velos Orbitrap mass spectrometer (Thermo 
Fisher Scientific, Inc., Waltham, MA) as described previously [164] with the exception 
that the Higher-energy Collisional Dissociation (HCD) activation energy was 20 ms..  
The mass spectrometer RAW data (Proteowizard files) were converted to 
mzXML using MSconvert software and to MGF files using TINT raw-to-mgf converter. 
ProteinPilot 4.5 (AB Sciex, Foster City, CA) searches were performed against the NCBI 
reference sequence for the I. scapularis (taxon 6945; November 14, 2011 version) protein 
FASTA database with canonical and isoform sequences (20468 proteins), to which a 
NCBI reference sequence A. phagocytophilum str. HZ (taxon 212042; November 14, 
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2011; 1267 protein) and a contaminant database (thegpm.org/crap/index, 109 proteins) 
was appended.  Search parameters were: cysteine  
MMTS; iTRAQ 8plex (Peptide Labeled); trypsin; instrument Orbi MS (1–3ppm) 
Orbi MS/MS; biological modifications ID focus; thorough search effort; and False 
Discovery Rate analysis (with reversed database). 
* These sections were written by the staff at the Mass Spectometry Laboratory at the 
University of Minnesota. 
 
Function and Pathways of Differentially Expressed A. phagocytophilum Proteins.  
The putative function of all the differentially expressed proteins identified by 
iTRAQ was determined using the databases in NCBI  (www.ncbi.nlm.nih.gov) to identify 
conserved domains, Uniprot (http://www.uniprot.org/uniprot/), EMBL-EBI 
(http://www.ebi.ac.uk/interpro/IEntry?ac=IPR000866), and OMA 
(http://omabrowser.org). Pathways which involved proteins differentially expressed 
during infection with the OMT-mutant compared to wildtype were identified with 
KEGGS (http://www.genome.jp/kegg/tool/map_pathway1.html).  
 
Identification of Differentially Methylated Proteins 
To identify the peptides that differed in their methylation, a text file of data for all 
peptides was imported into Xcel (Microsoft, Redmond, WA), and entered into 
TextWrangler (Bare Bones Software, North Chelmsford, MA). Peptides that were less 
abundant in the mutant when compared to the wild-type were selected and the intensity of 
spectra was analyzed using Protein Pilot to confirm differences.   
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Production and Testing of Functional Recombinant OMT 
 A functional version of the OMT without the sTag (rOMTns) was produced as 
described previously. After eluting the protein was dialyzed as described for non-
functional protein. rOMTns was used  in methylation assays using A. phagocytophilum 
and ISE6 cells lysates as substrates to evaluate the activity of the enzyme. A. 
phagocytophilum lysates were produced from bacteria purified from 75 ml flasks of 
infected HL-60 cells and lysed with ProFound Lysis Buffer (Thermo Scientific, 
Rockford, IL) for 2 hours at 4 °C. ISE6 cell lysates were produced from confluent cell 
layers in 25 cm2 flasks using the same procedure as for A. phagocytophilum lysate. 
Concentration of the protein in lysates was measured using the BCA protein assay. 
Lysates were dialyzed as described for recombinant proteins and then frozen at -70 °C to 
inactivate any possible methyltransferase activity. 
 The SAM-fluoro: SAM Methyltransferase Assay (Gbiosciences, St. Louis, MO) 
was used to measure the activity of the enzyme. A total of 50 ηg rOMTns was used along 
with a total of 40 ηg of protein from the lysates. Methylation was measured by the 
excitation of resorufin after the generation of AdoHcy (adenosine homocysteine) by 
SAM-dependent methyltransferases. Resorufin production was determined in a Synergy 
H1 Hybrid microplate reader (Biotek, Winooski, VT) during a kinetic run measuring the 
fluoresce at an excitation wavelength of 530nm and an emission wavelength of 585nm 
every two min for 2 hr at 34°C. Reactions were carried out in a 96 well EIA/RIA plate 
flat bottom plate (Costar, Corning, NY) covered with a MicroAmp optical adhesive film 
(Applied Biosystems, Grand Island, NY) to protect samples from evaporation. Negative 
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controls included the lysates or the rOMTns alone without the enzyme or substrate, 
respectively, in the reaction buffer with AdoMet. Positive controls included the addition 
of AdoHcy with the rOMTns and the positive control enzyme provided by the 
manufacturer. Statistical significance was measured with One-Way ANOVA in repeated 
measurements (SigmaStat). 
 
Production of recombinant proteins for substrate testing 
Possible substrates identified by iTRAQ where produced as recombinant proteins 
using the pET29a vector (Novagen). Primers to amplify partial or complete coding 
sequences where designed with restrictions sites for NdeI and XhoI enzymes, using the 
primer sequences listed in Table 1. Inserts were amplified using pfu enzyme under 
conditions listed in Table 2. Products were purified, replicated, and the integrity of the 
sequences in the plasmids was confirmed by Sanger sequencing as described. Plasmid 
constructs were then cloned into BL21(D3) E. coli (New England Biolabs, Ipswich, MA) 
for expression. Proteins were produced in 150 ml of superior broth induced with 200 µM 
IPTG, above, and used in methylation assays as described below.  Proteins concentrations 
were measured using BCA micro protein assay kit (Pierce).  
 
Methylation assay of potential substrates 
Methylation of different proteins in the two lysates was tested with the 
SAMfluoro: SAM Methyltransferase Assay, as previously described in the section 
Production and testing of functional recombinant OMT. Assays were performed with 50 
ng of the enzyme and 40 ng total proteins for substrates and lysates, as specified by the 
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manufacturer. Kinetic measurements were done every 2 min for 4 hrs. Statistical 
significance was measure with One-Way ANOVA in repeated measurements 
(SigmaStat).  
 
Putative tertiary structure and localization of methylated residues 
 Phyre2 (http://www.sbg.bio.ic.ac.uk/~phyre2/html/page.cgi?id=index) was used 
to determine the putative tertiary structure of the proteins that were identified as being 
methylated by the iTRAQ analysis as well as the in vitro methylation assay. The putative 
localization of the modified residues was determined from the protein sequence and the 
structure generated from Phyre2.  Phobius (http://phobius.sbc.su.se/cgi-bin/predict.pl) 
was used to determine where the modified residues were located within the membrane of 
the bacteria since Msp4 is a surface protein [165].   
 
OMT is expressed by A. phagocytophilum interacting with tick cells 
 
According to the results from the previous analyses, OMT expression correlated 
with the binding of the bacteria to ISE6 cells and the mutation of the gene encoding the 
enzyme affected the ability of the bacteria to bind to host cells (previous chapter). 
Therefore, I was interested in the expression and localization and the expression of the 
protein during binding. Antiserum against the recombinant version of the complete OMT 
was produced to localize the protein during binding to ISE6, using Immuno Fluorescent 
Assays (IFA). The expression and localization of wild-type HZ OMT during incubation 
with ISE6 cells for 2 h was analyzed using a binding assay and immunofluoresence 
labeling as described above. Expression of the OMT was detected using mouse anti-OMT 
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serum and anti-mouse IgG conjugated to TRITC (red fluorescence) whereas bacteria 
were labeled with dog anti-anaplasma serum and FITC-conjugated anti-dog IgG (green 
fluorescence). Thus, co-localization of the enzyme with the bacteria resulted in a yellow 
signal (Figure 1A-B). Unbound bacteria or bacteria not interacting with ISE6 cells did not 
express the OMT and only green fluorescence was observed (Figure 1B).  The results 
demonstrated that only bacteria interacting with ISE6 cells expressed the OMT (Figure 
1A-B). Bacteria incubated with pre-immune serum did not fluoresce red (Figure 1C) and 
uninfected ISE6 cells incubated with anti-OMT followed by TRITC-conjugated anti-
mouse IgG did not show any red fluorescence either (negative control; Figure 1D), 
demonstrating that the serum specifically interacted with the OMT. This correlates with 
the previous results and corroborates the hypothesis that the enzyme methylates a 
bacterial protein that is important during binding to ISE6 cells. 
 
Mutation of OMT results in the differential expression of several A. phagocytophilum 
proteins 
 
To identify the proteins that were differentially expressed in the omt-mutant 
compared with the wild-type bacteria, I used a proteomic approach. Peptides in each 
sample were labeled with isotopic tags of known mass. Both mutant and wild-type 
bacteria were incubated with ISE6 cells and allowed to bind to the cells for 4 hrs at 34°C 
without agitation. Proteins were extracted from pellets of bacteria purified from host cells 
by passage through a small-bore needle as described earlier, and triplicate samples were 
analyzed by tandem mass spectrometry (MS/MS). In each replicate, multiple A. 
phagocytophilum proteins were identified that appeared to be differentially expressed in 
the mutant as compared to wild-type bacteria (data not shown). However, only 24 A. 
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phagocytophilum proteins (Table 3) were identified as differentially regulated in all 
replicates. Among these, 5 proteins were downregulated (hypothetical protein 
APH_0406, major surface protein 4, glutamine synthetase type 1, anti-oxidant AhpCTSA 
family protein, and ankyrin (GI88607707)), whereas the remaining 19 proteins were 
upregulated (Table 3). Glutamine synthetase type 1, hypothetical protein APH_0406, and 
major surface protein 4 (Msp4) presented the lowest relative expression ratios (>0.2), 
suggesting that they are highly expressed in HZ wild-type during binding to ISE6 cells 
compared to the mutant (Table 3). Several proteins known to be highly expressed [54], or 
known to be involved in infection of mammalian cells [55,130], were upregulated in the 
mutant (Table 3). These proteins included several membrane proteins (P44-18ES, an 
OmpA  family protein, P44-1 Outer membrane protein, an OMP85 family outer 
membrane protein, and hypothetical protein APH_0405) as well as stress response 
proteins (co-chaperone GrpE, chaperonin GroEl, and chaperone DnaK) (Table 3). This 
suggests that unlike HZ wild-type, the omt mutant possibly did not respond to the 
interaction with ISE6 cells in a host cell specific manner and did not change the 
repertoire of proteins in its outer membrane as a result. An analysis of proteins expressed 
by HZ wild-type vs omt mutant bacteria when binding to or replicating in HL-60 cells 
could answer this question. Additionally, it is possible that selection favored a population 
in which the repertoire of expressed outer membrane proteins differs from that of the 
parent for reasons unrelated to the mutation. It is also possible that lack of OMT 
disrupted an environmentally responsive regulatory mechanism or sensor that prepares A. 
phagocytophilum for changes in hosts. An analysis of the pathways that were affected by 
the omt mutation showed that several proteins involved in transcription and protein 
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metabolism were also upregulated, suggesting that the mutant was metabolically active; 
whereas only proteins involved in purine and pyrimidine metabolism were downregulated 
(Table 4).  
 
Identification of possible OMT substrates by iTRAQ 
Anaplasma and host cell peptides marked in iTRAQ results as having a methyl 
modification were analyzed to identify those that were less abundant in the omt mutant, 
and in mutant-infected cells. After examination of the spectra of each peptide in A. 
phagocytophilum, only peptides with a <0.7 ratio between the wild-type and mutant were 
considered to display reduced methylation. Those peptides with >0.7 were not considered 
as significant for further analysis since the spectra from mutant and wild-type displayed 
similar levels (Figure 2). This analysis identified eight A. phagocytophilum proteins with 
reduced methylation of 8 corresponding peptides (Table 4). Two of the proteins, Msp4 
and APH_0406, were downregulated in the mutant as well as being less methylated, 
highlighting their importance during tick cell infection. The affected amino acids were 
the glutamic acid resides (E) in the Msp4 peptide VEVEVGYK, and the asparagine 
residue (N) in the APH_0406 peptide NVVLGGMLK (Figure 3A and B). These were 
also the same peptides with the greatest reduction in abundance in the mutant compared 
to HZ wild-type (Table 5). However, the non-methylated versions presented less of a 
difference in abundance, on average yielding a ratio of 0.2199 for the Msp4 peptide in the 
mutant versus the HZWT, and 0.9243 for APH_0406 (Figure 4A and B). This suggested 
that in both proteins the non-methylated version of these peptides was more abundant, 
especially in APH_0406 in which the difference was minimal. This result confirmed the 
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low level of confidence in the identification of a non-methylated APH_0406 peptide 
(>1%), whereas confidence in the identification of the Msp4 non-methylated peptides 
was from 77 – 99% (Figure 4A and B).   
Likewise, several proteins in tick host cells displayed reduced methylation when 
infected with the omt mutant vs when infected with HZ wild-type (Table 6). A total of 15 
proteins and 17 peptides (two proteins presented changes in two peptides) showed 
reduced methylation. However, only one peptide of these I. scapularis proteins yielded a 
ratio of <0.4, in contrast to A. phagocytophilum proteins (Table 6).  This peptide was 
present in a heat shock protein (GI:241263225) and showed a ratio of 0.2999 in the 
second glutamic acid residue of DGILTIEAPLPALEAPNR (Table 6). All other peptides 
showed a less significant reduction in methylation. However, this protein was only found 
to be downregulated in one of the iTRAQ replicates (data not shown), questioning its 
significance as one of the substrates. Prolyl 4-hydroxylase alpha subunit (GI:240974259) 
and flavonol reductase/cinnamoyl-CoA reductase (GI:241703753) were the only two I. 
scapularis proteins to be downregulated in all replicates and to present peptides with a 
reduction in their methylation (Table 6). However, the reduction in methylation of the 
peptides in this protein was not as significant, with ratios of ~0.65 for flavonol 
reductase/cinnamoyl-CoA reductase and ~0.70 for prolyl 4-hydroxylase alpha subunit 
(Table 6). 
 
Recombinant OMT methylates A. phagocytophilum and I. scapularis lysates 
 To test if the proteins identified with the iTRAQ were in fact methylated by the 
OMT, a recombinant version of the OMT was produced in E. coli using the complete 
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coding sequence of the gene aph_0584 and removing the S-tag from the pET29a vector. 
The purity of rOMT was verified by gel electrophoresis (SDS-PAGE) of the eluted 
protein and Coomassie blue staining (Figure 5). The molecular weight (MW) of the 
purified rOMT corresponded with the predicted MW of ~24KDa (Figure 5). Two higher 
molecular weight proteins present in the uninduced E. coli lysate were also purified 
during the elution. Methylation assays using only the eluted rOMT along with all the 
reagents except for the substrate (negative control) did not demonstrate any detectable 
increase in fluorescence of these contaminant proteins, discarding the chance that they 
affected the results obtained in the other samples (Figure 6). On the other hand when the 
rOMT was incubated along with the positive control consisting of Adenosine 
Homocystein as acceptor of the methyl group, there was a rapid increase of the 
fluorescence (Figure 6). Likewise, when the assay was done using lysates from purified 
A. phagocytophilum or uninfected ISE6 cells lysates, there was an increased detection of 
fluorescence overtime (Figure 6), with increments in fluorescence as efficient as those 
detected with the positive control (Figure 6). Both results, however, indicate that the 
rOMT was active and suggested that possible substrates were present in the tick and A. 
phagocytophilum lysates.  
 
In vitro methylation assay confirms the methylation of Major Surface Protein 4 (Msp4) 
 Recombinant versions of some of the proteins identified with the iTRAQ as 
differentially methylated between the mutant and the wild-type bacteria were produced in 
E. coli. The proteins were purified and used in an in vitro methylation assay as described 
above. The purity of the proteins was confirmed as done with the rOMT (data not 
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shown). Because a plateau was not reached during the methylation assays above, using 
bacterial and host cell lysates, the reaction was allowed to proceed for 4 hours, so that 
fluorescence measurements would yield a typical enzyme activity curve. Four 
recombinant A. phagocytophilum proteins were tested using this methylation assay: 
Msp4, APH_0406, TypA, and P44-16b. I selected these proteins from eight candidates 
that yielded expression ratios of <0.60 (Table 5) because they presented the strongest 
reductions in the expression ratios. Production of recombinant preprotein translocase 
subunit SecA was unsuccessful with any of the E. coli strains used. Of the four proteins 
produced, the only protein that resulted in a significant increase in resorufin activation 
was Msp4 (Figure 7). APH_0406, TypA, and p44-16b produced high background 
fluorescence that resulted in high initial readings (~1500 – 2000 RU), but did not 
continue to accumulate a significant number of activated resorufin units, and only 
reached values of ~2100 RU (Figure 7). Also, the readings did not yield a typical enzyme 
activity curve like that obtained using Msp4 as the substrate. By contrast, we Msp4 was 
used as the substrate the fluorescence started at a lower reading (~1300 RU) but reached 
higher values (~3400 RU) and reached to present a plateau at around 210 min after the 
reaction was initiated (Figure 7).  
 
Putative positioning of methylated residues in Msp4 
 The tertiary structure of Msp4 was predicted using Phyre2 that compares 
conserved residues of a query protein to the sequence of proteins with known crystallized 
structures. The predicted tertiary and secondary structures were used to predict the 
probable positioning of the methylated residues. Msp4 was predicted to form a beta-
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barrel typical of porins and the glutamic acid residues that are modified by the OMT are 
positioned at the start of one of the beta-strands forming the beta-barrel (Figure 8A and 
B). Furthermore, transmembrane and signal peptide prediction software suggested that 
the first ~30 aa residues represented a signal peptide to direct transport of the protein 
from the cytoplasm to the outer membrane (Figure 8C). These residues correspond to the 
alpha helix at the N-terminus (dark blue) that is probably cleaved before the protein is 
positioned in the outer membrane (Figure 8B and C). The protein does not contain 
predicted transmembrane domains, but it is very likely that its positioning in the outer 
membrane is similar to that reported in other porins in that the beta- barrel spans the 
membrane, and the portion of the protein with the longest loops is exposed on the outside 
of the bacteria. 
Discussion  
 Post-translational modification of molecules that function as adhesins and other 
bacterial virulence factors that respond to environmental conditions or interactions with 
host cells has been reported [115,118,166,167]. One such modification is the addition of 
methyl groups by methyltransferases that functionally modify a range of diverse acceptor 
molecules, such as DNA, RNA, or proteins [110]. Methylation of outer membrane 
proteins and virulence factors has been increasingly recognized as an essential process 
during host invasion and infection by several obligate and facultative intracellular 
bacteria [117,138,148,152]. For example, outer membrane protein OmpB is an immune-
dominant rickettsial antigen in several members of the genus Rickettsia that is known to 
be important for binding to and entry into mammalian cells in vitro [168], and is 
methylated by protein lysine methylases [115]. Methylation of proteins commonly occurs 
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by two types of methyltransferases: N-methyltransferases that modify lysine (K), arginine 
(R), or glutamine (Q), and O-methyltransferases that usually modify glutamic acid (E) by 
transferring a methyl group to the carboxyl residue, forming a methyl ester (as reviewed 
in [109]). Fifty four percent of the methyltransferases included in the subclass EC.2.1.1  
comprise enzymes that modify an oxygen (O) atom in acceptor molecules, making O-
methyltransferases (OMTs) the most common group of methyltransferases with the 
greatest genetic diversity and functional expansion [110]. Although, this group of 
enzymes has mostly been studied in plants and mammals [110], its importance in 
bacterial pathogenesis has been a subject of increasing interest [117]. O-methylation of 
outer membrane proteins has most commonly been linked to bacterial chemotaxis, signal 
transduction and adaptation to the environment [109,169,170]. More recent reports have, 
however, expanded the role of this modification in bacterial pathogenesis to include 
methylation of an outer membrane protein of Leptospira interrogans that has been shown 
to be important for bacterial binding to and infection of kidney cells [118]. 
Here, I report methylation of a major surface protein, Msp4, by an O-
methyltranferase (OMT) in A. phagocytophilum. In the previous chapter, I described the 
effects of the mutation of the gene aph_0584, which encodes an OMT family 3 member, 
on the ability of A. phagocytophilum to bind to and infect the embryonic I. scapularis cell 
line ISE6. In this chapter, I used IFAs to confirm the colocalization of the enzyme only 
with bacteria that are binding and interacting with ISE6 cells, as extracellular bacteria 
that were not bound to the tick cells were not recognized by the anti-rOMT serum (Figure 
1). This suggested involvement of the enzyme in the methylation of a molecule important 
for adhesion to and infection of ISE6 cells.  
95 
 
 
 
Proteomic analyses were then used to identify molecules that could be the 
potential substrates of the enzyme. iTRAQ, which can be used to quantify abundance of 
certain peptides in samples subject to different treatment conditions, revealed differences 
in peptide methylation of A. phagocytophilum and I. scapularis proteins. This technique 
identified several potential OMT substrates, two of which included A. phagocytophilum 
proteins that were previously shown to be highly expressed during infection of ISE6 
cells, i.e., Msp4 and APH_0406 [54]. Both of these proteins presented a substantial 
decrease in their methylation due to the mutation of the OMT (Table 5 and Figure 3). 
Methylation of Msp4 was further confirmed using in vitro methylation assays (Figure 7). 
Msp4 is an antigenic protein encoded by a single copy gene that is highly conserved 
between different strains of A. phagocytophilum [171], as well as other members of the 
genus Anaplasma [165]. Furthermore, Msp4 is a member of the Msp2 superfamily of 
proteins [172] and is homologous to another major surface protein from A. 
phagocytophilum, Msp2 (P44), which has been shown to also be post-translationally 
modified [173], has been demonstrated to be a porin [51], and to facilitate binding to 
mammalian cells [53]. Thus, it is very likely that Msp4 carries out similar functions and 
has a similar structure to those reported for Msp2 (P44), but that it completes this 
function in the arthropod vector.  
Several bacterial outer membrane proteins have been discovered to act as porins 
of various specificities and structures [174]. The most common “general” porins form 16-
strand beta barrels configured as trimeric peptide subunits and in most cases are non-
specific [174,175]. However, other less common porins, which have been shown to be 
more substrate specific, have been described and are comprised by 18-, 14-, 12-, and even 
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8- strands and in some cases are present as monomers (e.g., the 14 beta-stranded porins 
OmpG and CymA in Escherichia coli) [174]. Some of these porins have been shown to 
have double functionality since they can also act as adhesins [174]. The expression of 
porins depends on the environmental conditions experienced by bacteria as many porins 
only transport specific molecules (reviewed by Nikaido, 2003 [175]). Moreover, specific 
residues present on E. coli OmpC and OmpF affect the conformation and function of  
these porins [175]. Some porins have been shown to respond to cues in the environment 
by opening or closing, which regulates the entry or exit of specific molecules. One such 
porin is the 14-stranded porin OmpG from E. coli, that reacts to the pH in the 
environment and changes the conformation of its beta-strands, resulting in modifications 
of the arrangement of the outside loops,  which leads to closure of the gate [176]. This 
activity is mediated by two single residues, His231 and His261, that serve as pH sensors 
and trigger the changes in beta-strand 11 – 13 [176,177].   
Like OmpG [174], Msp4 possesses a signal peptide within the first 30 aa in the N-
terminus that probably directs transport to the membrane (alpha-helix shown in Figure 
8B). Analysis using Phyre2 additionally suggests that Msp4 is also a 14-beta stranded 
porin (Figure 8A and B), and the Msp4 homolog from the closely related bovine 
pathogen, A. marginale, was previously shown to exist as a monomer in the membrane of 
this bacterium [178]. Thus, is very likely that Msp4 is indeed a monomeric 14-stranded 
porin, similar to OmpG.  It is interesting to note that the glutamic acid residues (E) of 
Msp4 that appear to be important for binding and host cell invasion by A. 
phagocytophilum are close to one of the loops on the outside of the channel (Figure 3A 
and Figure 8B). Similarly, L. interrogants OmpL32 contains methylated glutamic acid 
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residues that are important for infection and colonization of kidney and liver cells [118]. 
It is possible that modification of glutamic acid residues in Msp4 is involved in the 
specificity of the porin’s channel during the binding of the bacteria to ISE6 cells and thus 
essential for the infection of this cell type. Additionally, methylation of these glutamic 
acid (E) residues could aid in chemotaxis of the bacteria towards host cells, as previously 
described for other  bacterial taxa [109]. A lack in the ability of the omt-mutant to 
respond to environmental changes when transferred from mammalian to tick cell cultures 
could explain the continued up-regulation of a set of proteins that are known to be 
important during infection of mammalian cells. Under these conditions, wild-type A. 
phagocytophilum bacteria presented a subset of proteins previously shown to be highly 
expressed in tick cell culture, or which have been reported to be involved in infection of 
ticks [54,55]. It is possible that in addition to a role in binding to host cells, methylation 
of Msp4 serves to sense changes in the environment including temperature and pH, such 
as occur when A. phagocytophilum is transferred from mammalian to tick hosts, or vice 
versa. These assumptions are supported by the finding that E. coli OmpG porin responds 
to changes in pH [176]. In this context, it is of interest to note that the gene encoding the 
OMT, APH_0584, is in close proximity to a sensor histidine kinase encoding gene 
(APH_0582), which is thought to be part of the two component systems of A. 
phagocytophilum [179]. However, more research is needed to determine the exact 
function of these methyl modifications of Msp4. This is the first report of the methylation 
of an outer membrane protein in A. phagocytophilum by an A. phagocytophilum O-
methylase, and its importance in infection of tick cells.     
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Conclusion 
As reported in the previous chapter, the OMT is important during binding of A. 
phagocytophilum in ISE6 cells. The binding process of bacteria to tick host cells is 
related to the methylation of the outer membrane protein, Msp4. Proteomic experiments 
done in this study showed that Msp4 is methylated at two glutamic acid (E) residues near 
position 130, which according to the prediction analyses corresponds to one of the beta-
strands that forms part of a beta-barrel porin structure. Thus, it is likely that the 
methylation of these residues is in response to the interaction with the ISE6 cells and 
affects the conformation and function of this protein, which in turns affects the ability of 
the bacteria to infect and develop in this cell type. 
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Figures and Tables 
Table 1. Primers used for the amplification of A. phagocytophilum and I. scapularis genes for the production of recombinant 
proteins. 
Primer name Primer sequence Protein target Organism 
rOMT Fw 5' GCT AGA GTC GAC TCA TGT GAG CTT TA '3 GI:88598384 A. phagocytophilum 
rOMT Rv 5' GCT CAG ATA TCG TGC GCA ATG TCT CT '3 GI:88598384 A. phagocytophilum 
rOMTns Fw 5' GCC AGA TCA TAT GGT GCG CAA TGT CT '3 GI:88598384 A. phagocytophilum 
rOMTns Rv 5' CTT TAG CGA ATT CCA TGT GAG CTT TAT '3 GI:88598384 A. phagocytophilum 
TypA Fw 5' TGA TCC TCG AGT GCA GCA TAT CCA TGG AAC AAT C '3 GI:88607727 A. phagocytophilum 
TypA Rv 5' GGA TCC ATA TGA TGT CGA GTG CCT ACG ATT CCA '3 GI:88607727 A. phagocytophilum 
p4416b Fw 5' ATA GCT CGA GCC TAA CAC CAA ATT CCC CAC CGA C '3 GI:88607043 A. phagocytophilum 
p4416b Rv 5' CAT ATG GTC ATG GCT GGG ACT GAT GTC AGG GCT '3 GI:88607043 A. phagocytophilum 
msp4 Fw 5' GTA GTG CAT ATG TAC AGA GAA TTG CTG GT '3 GI:88607879 A. phagocytophilum 
msp4 Rv 5' CGT AGC CTC GAG TCT TGC TCC TAT GTT GAA GCC G '3 GI:88607879 A. phagocytophilum 
aph0406 Fw  5' GAT AGC ATA TGA TAG TAG CGG TAA AAC GAG TA '3 GI:88607117 A. phagocytophilum 
aph0406 Rv 5' GTA TGT CTC GAG TAT AAC TTG ACC TCT ATT TAC AC '3 GI:88607117 A. phagocytophilum 
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Table 2. Annealing temperatures used for amplification of A. phagocytophilum genes for 
the production of recombinant proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primer set 
Annealing Temperature (°C) 
First 10 cycles Next 20 cycles 
pet29a-p44-16b 50 60 
pet29a - typA 43 53 
pet29a- msp4 45 52 
pet29a - aph0406 43 55 
pet29a-0906 46 56 
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Figure 1. OMT co-localization with bacteria during binding of A. phagocytophilum to ISE6 
cells. 
 (A-B) Bacteria are labeled with FITC-labeled antibodies in the green channel. A. 
phagocytophilum expressing the OMT were labeled with Rhodamine-labeled antibodies in the 
red channel. Bacteria expressing the OMT were co-labeled and visualed with a yellow color. C) 
Pre-immune mice serum was used as a negative control. D) Uninfected ISE6 cells were also used 
as negative control. 
  
 102 
 
Table 3. A. phagocytophilum differentially expressed proteins in the OMT-mutant 
Accession Number Protein ID Function Expression in K/O Ratio KO/Wt 
GI88607117 Hypothetical protein APH_0406 Hypothetical  Downregulated 0.1773 
GI88607879 Major Surface Protein 4 Hypothetical porin Downregulated 0.1190 
GI88607666 Glutamine synthetase, type 1 Amino acid metabolism Downregulated 0.0997 
GI88607183 Anti-oxidant AhpCTSA family protein Signal transduction Downregulated 0.8069 
GI88607707 Ankyrin Membrane interactions Downregulated 0.5898 
GI88606723 Chaperonin GroEl Stress response Upregulated 1.5489 
GI88607549 Chaperone DnaK Stress response Upregulated 1.1503 
GI88607105 DNA-directed RNA polymerase beta subunit  Transcription Upregulated 1.3672 
GI88607442 
Bifunctional proline dehydrogenase/pyrroline-5-
carboxylate dehydrogenase Amino acid metabolism Upregulated 1.2042 
GI88606872 DNA-directed RNA polymerase beta subunit  Transcription Upregulated 1.3873 
GI88607267 Hypothetical protein APH_0404 Unknown Upregulated 1.3778 
GI88607778 Polynucleotide phosphorylase/polyadenylase RNA metabolism Upregulated 1.5950 
GI88607654 Hypothetical protein APH_0405 Membrane Upregulated 1.3533 
GI88607567 OMP85 family outer membrane protein Membrane Upregulated 1.2934 
GI88607014 Leucyl Aminopeptidase Protein metabolism Upregulated 1.3933 
GI88606911 Hypothetical protein APH_0906 Unknown Upregulated 1.2636 
GI88607774 F0F1 ATP synthase subunit beta Energy metabolism Upregulated 1.2689 
GI88607426 P44-1 Outer membrane protein Hypothetical porin Upregulated 1.1646 
GI88607319 Translation initiation factor IF-2 Protein metabolism Upregulated 1.2237 
GI88606885 Hypothetical protein APH_1235 Unknown Upregulated 1.3020 
GI88607566 Co-chaperone GrpE Stress response Upregulated 1.3726 
GI88607299 OmpA  family protein Membrane Upregulated 1.3939 
GI88607721 Cytochrome C oxidase, subunit II Energy  Upregulated 1.6799 
GI88607259 P44-18ES, expression locus with P44-18 Hypothetical porin Upregulated 3.1262 
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Table 4. Pathways that involve proteins that showed a difference in expression in the OMT-
mutant during binding and internalization into ISE6 cells. 
 
 
 
 
 
 
 
 
 
 
Pathway Pathway ID # proteins downregulated 
Pyrimidine metabolism Aph00240 1 
Purine metabolism Aph00230 1 
Nicotinate and nicotamide metabolism Aph00760 1 
Pathway Pathway ID # proteins upregulated 
RNA degradation Aph03018 3 
Pyrimidine metabolism Aph00240 3 
Purine metabolism Aph00230 2 
Nitrogen metabolism Aph00910 2 
Oxidative phosphorylation Aph00190 2 
Alanine, aspartate, and glutamate 
metabolism Aph00250 2 
Arginine and proline metabolism Aph00330 2 
Glyoxylate and dicarboxylate metabolism Aph00630 1 
Two-component system Aph02020 1 
Glutathione metabolism Aph00480 1 
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Figure 2. Spectrum intensity in methyl modified peptides with ratios above 0.7 in A. phagocytophilum proteins. 
 The numbers under the 115:114 columns and the lines labeled 114.1108 and 115.1079 represent the ratios and intensities of the 
peptides in the wild-type bacteria. The numbers under the 116:114 and 117:114 fields represent the ratios of the peptides in the mutant 
bacteria compared to the wild-type and the lines labeled 116.1112 and 117.1146 represent intensities of the peptides in the mutant 
samples. 
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Figure 3. Spectrum intensity differences of the methyl modified peptides in MSP4 and APH_0406 in the OMT-mutant versus the 
wild-type A. phagocytophilum 
 The numbers under the 115:114 columns and the lines labeled 114.1108 and 115.1079 represent the ratios and intensities of the 
peptides in the wild-type bacteria. The numbers under the 116:114 and 117:114 represent the ratios of the peptides in the mutant 
bacteria compared to the wild-type and the lines labeled 116.1112 and 117.1146 represent intensities of the peptides in the mutant 
samples in A) Msp4 and B) APH_0406. 
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Figure 4. Spectrum intensity differences of the non-methyl modified peptides in MSP4 and APH_0406 in the OMT-mutant versus 
the wild-type A. phagocytophilum 
 The numbers under the 115:114 columns and the lines labeled 114.1108 and 115.1079 represent the ratios and intensities of the 
peptides in the wild-type bacteria. The numbers under the 116:114 and 117:114 represent the ratios of the peptides in the mutant 
bacteria compared to the wild-type and the lines labeled 116.1112 and 117.1146 represent intensities of the peptides in the mutant 
samples in A) Msp4 and B) APH_0406. 
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Table 5. A. phagocytophilum proteins with reduced peptide methylation in the OMT mutant  
* Proteins analyzed with the methylation assay. 
 
 
 
 
 
 
 
 
 
Accession 
Number Protein ID Peptides with modifications Ratio Wt:KO 
GI88607441 
Branched-chain alpha-keto acid dehydrogenase subunit 
E2 TLSELSK Methyl(S)@6 0.6651 
GI88607727* GTP-binding protein TypA INSQVK Methyl (N)@2 0.5106 
GI88607117* Hypothetical protein APH_0406 NVVLGGMLK Methyl(N)@1 0.1773 
GI88607879* Major Surface Protein 4 
VEVEVGYK Methyl(E)@4 
VEVEVGYK Methyl(E)@2 
0.109 
0.1178 
GI88607043* P44-16B Outer membrane protein 
TKDTAIANFSME 
Methyl(S)@6 0.4831 
GI88607849 Peprotein translocase subunit SecA RIDNQLR Methyl (D)@3 0.4966 
GI88607473 Phosphoribosylamine-glycine ligase VLVIGSGGR Methyl(I)@4 0.6483 
GI88607510 RNA polymerase sigma factor RpoD AVLADLR Methyl(D)@5 0.6772 
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Table 6. I. scapularis proteins that present a reduction in peptide methylation in the omt-mutant infected cells 
Accession 
Number Protein ID Peptides with modifications Ratio Wt:KO 
GI241044082 3-phosphoglycerate kinase, putative ALDNPSRPFLAILGGAK Dimethyl(R)@7 0.4780
GI241157545 Actin, putative YPIEHGIVTNWDDMEK Methyl(H)@6 0.7378
GI241326700 Cell division protein, putative LYEFPCDDEEENKR Methyl(D)@8 0.6880
GI241104748 Fasciclin SFFNNMLLQTAEGDDKIR Methyl(D)@14 0.6323
GI241703753 
Flavonol reductase/cinnamoyl-CoA reductase, 
putative 
EVLEIEPR Methyl(E)@6 Methyl(E)@4 
LLLEDGQLR Methyl(E)@4 
0.6495
0.6523
GI241558809 Glycoprotein gC1qBP, putative  IEGFDVK Methyl(D)@5 0.6467
GI241263225 Heatshock protein 20.6, putative DGILTIEAPLPALEAPNR Methyl(E)@14 0.2999
GI241830514 Hsp90 protein, putative 
DQVANSAFVER Methyl(D)@1 
LMKDILDIL Methyl(D)@7 
0.7276
0.5119
GI241600204 
Phosphatidylinositol-4-phosphate 5-kinase 
type II, putative AEQEAVER Methyl(E)@7 0.5439
GI241586870 Plexin domain-containing protein, putative DLPVPVTEIPDK Methyl(D)@1 0.6624
GI240974259 Prolyl 4-hydroxylase alpha subunit, putative GDDGDVPMDEAAVGK Methyl(E)@10 0.6978
GI241627626 RNA-Binding protein musashi 
RGGGGGASGGGGGYHPYSR 
Dimethyl(R)@1 0.4190
GI241720809 TraB domain-containing protein, putative AVQEAEK Methyl(E)@4 0.4417
GI242004214 Ubiquitin-activating enzyme E1, putative ITAHENR Methyl(N)@6 0.6694
GI241061134 
Voltage-dependent anion-selective channel, 
putative VNASLETK Methyl(E)@6 0.6737
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Figure 5. Eluted recombinant OMT visualized in stained protein gel. 
 The eluted recombinant version produced in E. coli BL21(DE3) cells visualized by 
Coomasie blue staining after running in 4-16% gel for 1 hour. Protein standards were loaded in 
the first lane on the left, the second lane (U) contains lysate from uninduced E. coli cells and 
the last lane (P) contains the eluted protein after His-tag purification with nickel columns. The 
black arrow head points at the purified protein and the two small gray arrows show proteins 
from unspecific binding.  
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Figure 6. Methylation activity of the rOMT during incubation with A. phagocytophilum and 
I. scapularis lysates.  
 Enzymatic activity of the rOMT was measured by the increments in fluorescence in 
each sample. The lines represent the average fluorescence in each sample for that given time 
point from three replicates. The red line represents the change in fluorescence when the tick 
lysate was used in combination with the rOMT. The back line represents the activity of the 
rOMT using Ap lysate as substrate. 
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Figure 7. In vitro methylation of recombinant A. phagocytophilum proteins by rOMT 
 Enzymatic activity of the rOMT was measured by the increase in fluorescence 
(Resorufin units) in each sample. The lines represent the average fluorescence in each sample 
at that given time point from three replicates. The blue dotted line represents the reaction using 
Msp4 as the substrate, which is the only reaction that shows an exponential phase that reached 
a plateau at around 1 hr 30 mins, typical of an enzymatic reaction. The reactions with 
APH_0406, TypA, and p44-16b as substrates are represented by the black line, a dotted red 
line, and dotted gray line, respectively. The control is represented by a green dotted line, but it 
did not pass background levels.  
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Figure 8. Msp4 putative tertiary structure and potential positioning of methylated glutamic 
acid (E) residues 
A) Putative secondary structure of Msp4 protein sequence according to Phyre2. 
The yellow square shows the position at the beginning of the 7th beta strand. B) Msp4 tertiary 
structure showing the typical porin-like structure form by several beta-strands. The black arrow 
shows the potential positioning of the modified glutamic acid residues. C) Msp4 
transmembrane and signal peptide prediction. The red line represents the positioning of a 
signal peptide according to the protein sequence from GenBank and its probability. The blue 
line represents the portion of the protein that is non-cytoplasmic and the probability of a right 
prediction.  
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Chapter 4 
 
 
 
The Anaplasma phagocytophilum hypotethical protein APH_0906 is secreted into the 
cytoplasm of mammalian host cells 
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Introduction 
 
Anaplasma phagocytophilum is an obligately intracellular organism and a 
member of the Anaplasmataceae family along with several pathogens of human and 
veterinary importance [5]. A. phagocytophilum has been recognized as an important tick-
borne pathogen of ruminants for over 200 years in Europe, where the infection with this 
organism has been known as “tick-borne fever”, causing important economic losses in 
many countries [25,27,180]. However, in 1994 three cases of human infection with this 
pathogen, human granulocytic anaplasmosis (HGA), were reported for the first time [4], 
and since then the number of human cases have been increasing steadily, making HGA 
the second most commonly diagnosed tick-borne illness in the US [123]. The human 
version of the disease is also gaining importance in Europe [181] and Asia [182]. A. 
phagocytophilum is a zoonotic pathogen known to also infect horses, dogs, cats, rodents, 
domestic and wild ruminants, wild boars, foxes, and thus has a broad vertebrate host 
range [158]. A characteristic of this organism is its development inside a vacuole to form 
a “morula” [5] and it is one of the few bacteria that are capable of infecting 
polymorphonuclear leucocytes, also known as neutrophils, and its progenitors [183] as 
well as endothelial cells [85].  
 Because of the intracellular nature of A. phagocytophilum and the harsh 
environment where it develops, within neutrophils, the survival of this bacterium relies 
on its ability to influence and hijack the host’s defensive machinery and metabolism in 
order to avoid being killed and to obtain nutrients necessary for its growth [62]. Several 
studies have shown that infection with A. phagocytophilum affects the gene expression 
[74], cytokine production [184], and the ability of neutrophils to adhere to endothelial 
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cells [185]. It also inhibits apoptosis in neutrophils and tick cells [186,187], and co-opts 
the host cell’s transport system to obtain cholesterol and nutrients [188,189]. These 
activities, which are shared among pathogens in the family Anaplasmataceae [190], rely 
on effectors in order to manipulate host cell survival [191]. Although only two proteins 
have been experimentally shown to be translocated into the cytoplasm and nucleus of 
host cells during A. phagocytophilum infection [191], it is very likely that additional 
effectors are encoded within the bacterium’s genome.   
 A. phagocytophilum is an organism with a small genome (~1.5 Mbps), but over 
70% of its genome encodes to hypothetical genes [128]. Over 40% of A. 
phagocytophilum genome encodes hypothetical proteins and conserved hypothetical 
proteins. These hypothetical genes comprise the majority of the genes that are unique to 
this bacterium [128]. One such unique A. phagocytophilum gene encodes the hypothetical 
protein APH_0906 predicted to be an outer membrane protein that is highly expressed 
during infection of HL-60 and HMEC-1 cells, as demonstrated by whole genome tiling-
array analysis [54]. A mutant resulting from transposition of a GFPuv marker gene and 
spectinomycyn resistant gene [108], into the APH_0906 locus of A. phagocytophilum is 
unable to grow in HL-60 cells as reported in Chapter 2. This mutant demonstrated a slight 
decrease in its ability to bind to these cells, and was further defective for development in 
RF/6A and HMEC-1 cells, but able to infect hamsters. In this chapter, I present evidence 
for translocation of the protein into the cytoplasm and nucleus of infected HL-60 cells as 
well as in HL-60 and HMEC-1 cells transfected with a construct encoding the entire 
APH_0906 region. I also determined the relationship and similarities between the 
homologs of this gene from several strains of A. phagocytophilum.   
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Materials and Methods 
 
Recombinant protein production 
 Due to the size (4587 bp) of the APH_0906 locus, recombinant versions of the 
two halves of the APH_0906 protein were produced using the pET29a expression vector 
(Novagen, Germany). The portion between nucleotides 965395 – 967663 was amplified 
using primers APH_0906 fw1 (5’-  ATG GTA GCA TAT GAT GAC TCT GCT GCT 
TAA GCC AAA C – 3’) and APH_0906 rv1 (5’ - GTG ATG CCT CGA GAT CGA TCA 
GAG TGT CAC CGA GCA T – 3’) to obtain the first half of the protein (r1APH_0906), 
and the second half (r2APH_0906), located between nucleotides 967516 –  969978 was 
generated using primers APH_0906 fw2 (5’- GTG CGA TCC ATG GAA GAA GAT 
GGT ACC GCG T – 3’) and APH_0906 rv2 (5’ - ATT GCT TAG CTC GAG ATG CTG 
CTG CTG TGA TAC G – 3’). PCR employed pfu DNA polymerase (Promega, Madison, 
WI) under the following conditions: one denaturing cycle at 94 °C for 3 min, 10 cycles 
with a denaturing step at 94 °C for 1 min, 48 °C for 1 min for annealing, and extension at 
72 °C for 2 min, then 20 additional cycles with a denaturing step at 94 °C for 1 min, 60 
°C for 1 min for annealing, and extension at 72 °C for 2 min, and a final extension step of 
7 min at 72 °C. The amplified products were digested with the restriction enzymes XhoI 
and NdeI (r1APH_0906) and XhoI and NcoI (r2APH_0906), followed by ligation into the 
vector (pET29a) at 15°C overnight. Plasmids were cloned into One Shot® TOP10 
competent cells (Invitrogen, Grand Island, NY) for replication, and purified using the 
High pure plasmid isolation kit (Roche, Indianapolis, IN).  The integrity of the plasmid 
was checked by sequencing with the T7 promoter (5’- TAA TAC GAC TCA CTA TAG 
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GG – 3’) and the T7 terminator (5’- GCT AGT TAT TGC TCA GCG G – 3’) primers at 
the Biomedical Genomics Center (the University of Minnesota). Sequences were 
reviewed using MacVector 12.5 (MacVector, Inc., Cary, NC) and when the integrity was 
confirmed plasmids were transfected into BL21(D3) E. coli (New England Biolabs, 
Ipswich, MA) for expression. BL21(D3) E. coli were inoculated into 100 ml of Superior 
Broth (AthenaES, Baltimore, MD) induced with 200 µM IPTG, final concentration, and 
incubated at 37°C overnight with constant shaking. Proteins were purified using Ni-NTA 
Fast Start Kit columns (Qiagen, Germantown, MD) and concentrations measured using 
the BCA protein assay kit (Pierce, Rockford, IL). The correct molecular weight of 
recombinant proteins was verified by electrophoresis on a 4 – 15% Mini protean TGX 
gels (Biorad, Hercules, CA) and bands visualized using silver stain (Biorad, Hercules, 
CA). 
 
Production of anti-APH_0906 antibodies 
 Both recombinant r1APH_0906 and r2APH_0906 were dialyzed against tris-
buffered saline (TBS) in 3 ml Slide-A-Lyzer Dialysis Cassettes with a 10KDa  molecular 
weight cut-off (Thermo Scientific, Rockford, IL). TBS was changed after 2 hr and 
dialysis continued overnight. Three 6 – 8 weeks old C57BL/6J mice (Jackson 
Laboratories, Bar Harbor, ME) were injected subcutaneously at the base of the tail with 
100 µg of each recombinant protein emulsified in TiterMax Research adjuvant (CytRx 
Co., Norcross, GA). Mice were given a second and third booster injection with 100 µg of 
each recombinant protein 14 days and 24 days later. To obtain antiserum, blood was 
collected 10 days after the third booster by heart puncture after CO2 euthanasia. Serum 
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from mice of the same cohort but that were not immunized with the recombinant protein 
was used as a control. Serum was prepared by incubating the blood at 37 °C for 60 min, 
the clot was separated from the wall of the centrifuge tube, and clotted blood was held at 
4 °C overnight. Serum was collected after centrifugation at 1610 x g for 10 min and 
stored frozen at -20°C. 
 
Plasmid design for mammalian cell transfection 
 pIMGreen was used as the parent plasmid for the construction of pIM 0906. 
 pIMGreen was made by cloning the NotI/NheI fragment from pVITRO4-
nGFPLacZ_TDS (Invitrogen, San Diego, CA) into a plasmid between two IR/DR repeats 
recognized by the Sleeping beauty transposase. The IR/DR(L) repeats (Figure 1) were 
digested from pT-HB whereas IR/DR(R) was digested from pT-BH (Figure 1) [192]. The 
complete pIM-0906 was constructed by PCR amplification of the aph_0906 coding 
region in two fragments, one half was digested with NcoI, whereas the second half was 
digested with NcoI and AvrII. The two halves were ligated together and cloned into pIM 
GFP by replacing the GFP gene in the plasmid with the entire coding sequence of 
aph_0906. This was done to keep the size of the construct small enough to not affect 
transposition efficiency. Thus, the two IR/DR repeats flanked the entire aph_0906 and a 
Neomycin resistance gene (Figure 1), referred to as PIM-0906core.  
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Transfection of RF/6A, HMEC-1, and HL-60 cells with PIM-0906core containing 
complete APH_0906 
 RF/6A and HMEC-1 cells were routinely grown in 12.5 cm2 flasks with vented 
caps using 2.5 ml of RPMI medium supplemented with 10% Fetal Bovine Serum (FBS) 
and 2 mM of L-glutamine and then incubated at 37 °C in a humidified atmosphere of 5% 
CO2 in air. Confluent cells layers were subcultured by trypsinization (Gibco, New York) 
as follows: cell layers were exposed to 1 ml of trypsin with EDTA for 1 minute at 37°C, 
trypsin was aspirated, and cell layers incubated for an additional 4 min at 37°C. Cells 
were resuspended in 3 ml of growth medium, and 0.5 ml of the cell suspension was 
inoculated into a new flask containing 2 ml fo fresh supplemented RPMI medium. This 
was repeated every two weeks.  
 For transfection, RF/6A and HMEC-1 cells were subcultured as described, except 
that 1 ml of cell suspension was inoculated into a 12.5 cm2 flask containing 1.5 ml of 
medium. Cells were incubated at 37°C as described above for 24 hr and then transfected 
at 50 – 57% confluency using Lipoafectamine 2000 (Invitrogen, Grand Island, NY) as 
follows: 2.5 µg of PIM-0906core and 2.5 µg of SB11 ([193] and Figure 2) plasmids, 
which is the plasmid containing the transposase, were mixed with 100 µl OPTI-MEM I 
(Gibco, Grand Island, NY) in 0.5 ml microcentrifuge tubes and combined with 100 µl 
OPTI-MEM I plus 12.5 µl of the Lipoafectamine reagent. Plasmids and Lipoafectamine 
were mixed by flicking the tubes gently for 20 sec followed by 5 min incubation at room 
temperature. Lipoafectamine-plasmid complexes were then inoculated onto RF/6A or 
HMEC-1 layers in 2 ml of OPTI-MEM I. Cell layers were incubated at 37°C for 1 – 3 
days for transfection to occur, after which time the transfection medium was replaced 
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with RPMI medium containing G418 (100 µg/ml for RF/6A and or 5 µg/ml for HMEC-1 
cells) for selection of transformed cells.   
 To transfect HL-60 cells, the procedure was modified to accommodate non-
adherent cells (growing in suspension) using a transfection protocol from Invitrogen. HL-
60 cells were counted with a hemacytometer and ~1x105 cells resuspended in 0.5 ml of 
RPMI supplemented with 10% FBS and 2 mM of L-glutamine were seeded into a 48 well 
cell culture plate. SB11 and PIM-0906core (0.5 µg each) were diluted in 100 µl of OPTI-
MEM I, 1.75 µl of Lipofectamine 200 was added, and the mixture was incubated for 25 
min at room temperature to allow for the formation of complexes. Plasmid-
Lipoafectamine complexes (100 µl) were added to each well containing HL-60 cells. 
Plates were incubated at 37°C in a humid atmosphere of 5% CO2 in air for 3 days for 
transfection to occur and 0.5 mg/ml of neomycin was then added for selection. After 1 
week, cells were expanded in 25 cm2 flasks with 20 ml of growth medium containing 
selection agent at 0.5 mg/ml. 
 Expression of the APH_0906 protein was verified by western blot. Three weeks 
after transfection of endothelial and HL-60 cells, protein was extracted from whole cells 
in 2x sample buffer (6mM Tris-HCL, 10% glycerol, 2% SDS, 5% 2-mercaethanol, and 
0.1% bromophenol blue ) heated to >95°C for 5 min and centrifugated at 21,000 x g for 
10 min to remove insoluble debris. Protein concentrations were measured using the BCA 
protein assay kit (Pierce, Rockford, IL) and 40 ηg of protein was loaded into protein gels 
as described in Chapter 3. MultiMark (Invitrogen, Grand Island, NY) protein standard 
was run in the same gel to verify the size of the protein. Proteins were electrophoresed for 
1.5 hr at 100 V and transferred to an Immobilon-P membrane (EMD Millipore Billerica, 
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MA) at 30 V overnight at 4 – 6°C. The membrane was blocked for 1 hr using 5% no-fat 
dry milk in Phosphate buffered Saline (PBS) and then incubated with anti-r1APH_0906 
or anti-r2APH_0906 antiserum followed by labeling with anti-mouse horseradish 
peroxidase conjugated IgG. Protein bands were visualized using the Metal enhanced 
DAB substrate kit (Thermo Scientific, Waltham, MA) as specified by the manufacturer. 
 
APH_0906 localization assay 
 HGE2, a strain isolated from a patient from MN [92], wild-type bacteria were 
purified from fully infected ISE6 cell layers, after cells had lifted from the bottom of 25 
cm2 flasks, by vortexing the infected cells with 60/90 grit silicon carbide (Lortone, Inc., 
Mukilteo, WA) for 30 s followed by filtration through a 2.0 μm pore size filter and 
centrifugation at 700 x g for 5 min to remove any remaining cell debris. Bacteria were 
inoculated into 25 cm2 vented cap flasks containing HL-60 cells. To examine localization 
of APH_0906 during infection, 5 days p.i., 300 µl of an infected HL-60 culture was 
diluted with 700 µl PBS, and 40 – 60 µl of the cell suspension was spotted onto 
microscope slides by centrifugation with a Cytospin 4 centrifuge (Thermo Shandon, 
Asheville, NC). Cells were fixed with methanol and baked for 1 hr at 50 °C.  To further 
determine localization of the protein at specific times during bacterial replication, 
infection of HL-60 cells was synchronized as follows: wild-type bacteria from one 25 
cm2 flask containing fully infected cultures of HL-60 cells as described above for 
infected ISE6 cells. The cell-free bacteria were then combined with 2.5 x105 cells in a 1.5 
ml microcentrifuge tube containing 200 µl of supplemented RPMI medium and incubated 
for 30 min at 37 °C with mixing every 10 min and then transferred to 4 °C for an 
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additional 30 min to synchronize the bacterial entry. Cells were then centrifuged down at 
700 x g for 5 min at room temperature and unbound bacteria were removed by 3 washes 
with supplemented RPMI medium. Cells were added to a 15 ml tube containing 5 ml of 
supplemented RPMI and incubated at 37 °C. Samples were taken 1.5 hr, 12 hr, and 24 hr 
p.i. and centrifuged onto microscope slides as described above. 
 To observe localization of APH_0906 within transformed cells, RF/6A and 
HMEC-1 cells expressing the transgene were trypsinized, diluted 10-fold in PBS, and 60 
µl of the cell suspension spotted onto a microscope slide as described above. 
Transformed HL-60 cells were diluted and then spotted onto microscope slides as 
described for infected HL-60 cells. All cell spots of transformed cells were fixed in 
methanol for 10 min and dried at 50°C for 1 hr.  
APH_0906 protein was detected by incubation with r1APH_0906 or r2APH_0906 
antiserum diluted 1:250 in PBS with 3% bovine serum albumin (BSA). Cell spots were 
incubated with antibody in a humid environment for 2.5 - 3 hr at room temperature. The 
slides were washed 3 times in PBS and blocked in 3% BSA in PBS for 10 min. The 
protein was then labeled with an anti-mouse antibody conjugated with FITC (for RF/6A 
cells transformed with PIM-0906core) or Cy3 (for infected and transfected HL-60 cells) 
at 1:500 dilution by incubating spots for 1 - 2 hrs at room temperature. All A. 
phagocytophilum bacteria were labeled with dog anti- A. phagocytophilum  antibody and 
FITC labeled anti-dog IgG to aid in identification of the bacteria, as described previously 
but using a 1:500 dilution for the dog anti-serum. Cell nuclei were labeled using DAPI 
present in VectaShield mounting medium (Vector laboratories, Burlingame, CA). 
Samples were viewed with a Nikon Eclipse E400 microscope (Nikon Instruments, 
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Melville, NY) and imaged with a Nikon DXM1200 digital camera (Nikon Inc., Melville, 
NY), using Nikon ACT-1 software.  
 
Sub-cellular localization and identification of a putative Nuclear Localization Signal 
 The APH_0906 (GI:88597974) protein sequence was used to predict the putative 
subcellular localization of the protein within the bacteria and within the eukaryotic host 
cell in addition to other information. Subcellular localization, positioning of binding sites, 
amino acid composition, presence of transmembrane helices, and exposed residues were 
predicted using PredictProtein (https://www.predictprotein.org/). Since analyses using 
CELLO and P-sortb in Chapter 2 suggested that APH_0906 was an outer membrane 
protein which differed from the analysis done herein, Nuc-PLoc 
(http://www.csbio.sjtu.edu.cn/bioinf/Nuc-PLoc/) was used to verify the results obtained 
with PredictProtein. The presence of Nuclear Localization Signal (NLS) residues within 
the protein was predicted using NLS_Mapper (http://nls-mapper.iab.keio.ac.jp/cgi-
bin/NLS_Mapper_form.cgi), NucPred (http://www.sbc.su.se/~maccallr/nucpred/cgi-
bin/single.cgi), and NLStradamus (http://www.moseslab.csb.utoronto.ca/NLStradamus/).  
A region similar to BRO (chromatin-associated), anti-repressor motifs, and 
predicted NLSs was also predicted in the protein homolog from four additional A. 
phagocytophilum isolates (HGE1, Dog2, JM, and CRT38) from a human patient, a dog, a 
jumping mouse (Zapus hudsonius), and a black-legged tick collected from deer [32,194-
196]. A phylogenetic tree showing the relationship of these protein sequences was 
produced using MEGA 4.0 [136] after generating a sequence alignment of all the proteins 
in MacVector 12.0 (MacVector Inc, Cary, NC). Additionally, PredictProtein was used to 
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determine if the binding regions of the protein were conserved among the different 
homologs.  
 
Results 
 
APH_0906 is translocated into the cytoplasm and nucleus of HL-60 cells during 
infection with A. phagocytophilum 
 In Chapter 2, I reported the upregulation of the expression of APH_0906 during 
infection of HL-60 cells starting 72 hr (3 d) post-inoculation (late phases of infection). 
Because of those results, I performed Immunofluorescence Assays (IFAs) to determine 
the localization of APH_0906 during late phases of infection in HL-60 cells, which 
showed that the protein is secreted into the cytoplasm and translocated into the nucleus of 
infected cells (Figure 3). APH_0906 appears to be transported to the cytoplasm of the 
host cell from the morulae as the protein is observed surrounding the morulae, but not in 
association with bacteria inside morulae (Figure 3A and C). The protein appeared as 
granules that accumulated in the cytoplasm of infected cells surrounding large morulae 
and throughout the cytoplasm of infected cells. In some cases, it was not labeled by the 
anti-A. phagocytophilum but that can be visualized in the DAPI channel serum (Figure 
3A), probably due to inefficient labeling of the bacteria. In the nucleus the protein 
localized to diffused structures and was not evenly distributed as seen in the cytoplasm in 
most cases (Figure 3A and C). APH_0906 co-localized with bacteria released from cells 
that had lysed due to heavy infection (Figure 3B), and less so with extracellular bacteria 
that were seen binding to cells (Figure 3C). Uninfected cells incubated with the anti-
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APH_0906 serum were not labeled, suggesting that the serum raised against the 
recombinant protein was specific to APH_0906 (Figure 3D).  
To determine if a similar localization was observed at specific time points early 
and late during infection, infection of HL-60 cells infection was synchronized as 
described above. Synchronized cultures were sampled at 1.5, 12, and 24 hr p.i. and the 
localization of the protein was determined using IFAs, as described above. These 
experiments confirmed results obtained with unsynchronized cultures. Cells incubated for 
24 hr with bacteria contained several morulae and APH_0906 was observed both in the 
cytoplasm and in the nucleus (Figure 4A and B). In the nucleus, APH_0906 appeared in 
diffused islands and localized to parts of the nucleus (Figure 4A), whereas in the 
cytoplasm the protein appeared more granular and distributed randomly (Figure 4B).  At 
12 hr p.i (Figure 4C), the protein was found in the nucleus and cytoplasm of the host cells 
as well as localized to the morulae. At 1.5 hr, the protein mostly co-localized with 
individual bacteria and bacteria forming morulae (Figure 4D). APH_0906 protein was not 
detected in uninfected cells (Figure 4E), as reported above, and pre-immune serum did 
not label any protein or structure of A. phagocytophilum infected cells (Figure 4F). 
 
APH_0906 protein translocated into the nucleus of transformed HL-60 and RF/6A 
cells 
 In order to test whether or not the cells could express the APH_0906 protein, 
RF/6A cells were transfected with only the PIM-0906core plasmid (Figure 1) without the 
SB11 plasmid ([193] and Figure 2). This is referred as “first trasnfection” from herein. 
RF/6A cells transfected with PIM-0906core plasmid (first transfection) as well as those 
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transfected using the PIM-0906core plasmid and SB11 (second transfection) grew more 
slowly than wild-type cells (data not shown). After 3 weeks of continuous culture under 
G418 selection, RF/6A cells from both transfections were subcultured and samples were 
taken for protein extraction. Transfected RF/6A cells were subcultured every 3 – 4 weeks 
thereafter using a 1:2 dilution, reflecting their reduced growth rate compared to wild-type 
cells which were subcultured by 1:5 dilution every 2 weeks. Transfected cells expressed a 
protein of approximately ~160 kDa, migrating just above the 148 kDa marker (Figure 5A 
and B), which correlates well with the 166.8 kDa mass of APH_0906 predicted by 
Expasy (http://web.expasy.org/cgi-bin/compute_pi/pi_tool) and Science Gateway 
(http://www.sciencegateway.org/tools/proteinmw.htm). Protein samples from tranfected 
and wild-type cells were analyzed by Western blot to determine expression of APH_0906 
protein. The APH_0906 protein was detected in RF/6A cells after both transfection 
attempts (Figure 5A and B). Immunofluorescence assays (IFAs) identified the 
localization of the protein within transfected cells. Only a few (<1%) transfected cells 
from the “first transfection” showed expression of the protein after subculturing (data not 
shown). However, the cells that harbored the PIM-0906core plasmid showed strong 
expression of the protein localized to the nucleus of the cells (Figure 6). Furthermore, 
APH_0906 appeared to accumulate to some areas of the nucleus whereas other parts of 
the nucleus showed no protein presence at all (Figure 6). The maintenance of these cells 
was discontinued and cells were stored in liquid nitrogen. In the second transfection 
attempt using SB11 in RF/6A, the proportion of cells that expressed the protein increased 
to almost 80 % (data not shown) and this population of cells is considered to be 
transformed and is being continuously grown. 
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  By comparison, transfected HL-60 cells could be subcultured under selection with 
neomycin by passing around 6.4 x 104 cells to a new 25 cm2 flask containing fresh 
medium once a week. This subculture schedule was similar to that for wild-type HL-60 
cells. Samples for protein analysis were taken from transfected HL-60 cells after the 
second subculture (3 weeks after transfection). Like transformed RF/6A cells, 
transformed HL/60 cells expressed the APH_0906 protein (Figure 5B). Transfection of 
HMEC-1 cells was not achieved and APH_0906 was not detected by Western blotting 
(data not shown). IFAs with transfected HL-60 cells showed that the protein was 
translocated to and distributed in the nucleus of these cells similarly to what was 
observed in RF/6A cells (Figure 7). Transfection of cells with PIM-0906core in the 
presence of SB11 yielded a population of cells that exhibited greater variability in 
transgene expression; however, most of the cells expressed the protein in relatively high 
amounts (Figure 7). Thus, expression of the protein by two different cell lines resulted in 
the translocation of APH_0906 to the nucleus of the cells (Figures 6 and 7).  
 
Nuclear localization signals (NLSs) are conserved between human pathogenic A. 
phagocytophilum strains but differs in non-human pathogenic strains 
The sequences of several A. phagocytophilum strains are available in GenBank, 
including one isolated from a human (HGE1 accession numbers: NZ_APHH01000002.1 
and NZ_APHH01000001.1), one isolated from a dog (Dog2, accession number: 
CP006618.1), a jumping mouse isolate (JM, accession number: CP006617.1). There is 
also a sequence from a deer tick isolate Ap-Variant 1 found in white-tailed deer that has 
been shown to not infect mice and is suspected to not infect humans ([33]; CRT38 
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accession number: NZ_APHI01000001.1 and NZ_APHI01000002.1).  The putative 
protein sequences from all the homologs of APH_0906 in these genomes were analyzed 
to identify putative DNA binding domains, the BRO-domain, predicted subcellular 
localization, and the presence of putative Nuclear Localization Signals (NLSs). The BRO 
(antirepressor) domain was detected in APH_0906 homologs from all strains except the 
Ap-Variant 1 strain (CRT38) (Table 1), whereas the presence of several NLSs was 
detected in all the strains. Two of these NLSs were shared between all of the sequences 
(YRTAVKKVKLA at position 202 or 165 and KKPSTTVPKKPPRPARGAK at position 
1451) (Table 1). The NLS DLRKRHRWA identified by NLSMAPPER at position 388 
was detected only in the protein sequence of APH_0906 from the jumping mouse (Table 
1), while a putative NLS (ENAVKERMLPALTLYAKRIAKR at position 610) was 
present in all homologs except the one from Ap-Variant 1 (CRT38) homolog Table 1). 
APH_0906 from all sources was predicted to be an outer membrane protein 
(Psort), secreted (ProteinPredict) and translocated to the nuclei of the host cells (Nuc 
Ploc) (Table 1). Overall, the APH_0906 homolog from CRT38 presented the most 
differences in its protein sequence, only 82% identity with the other homologs, and was 
distinct from the cluster formed by the protein from the jumping mouse, dog, and human 
strains in a Neighbor Joining tree (Figure 8). Interestingly, the APH_0906 homolog from 
HGE1 was more closely related to that from dog strain than to the homolog from another 
human isolate, HZ (Figure 8). An analysis of all putative binding sites in APH_0906 
homologs revealed significant differences in the number and localization of binding sites 
throughout the different homologs (Figure 9). However, all except the HZ isolate 
contained a central and a C-terminal cluster binding site (Figure 9). APH_0906 from HZ 
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presented the most differences in the binding sites, which appeared to be more dispersed 
throughout the protein. The secondary structures of the different homologs and their 
exposed and hidden residues were highly conserved and almost identical (Figure 9).   
 
Discussion 
Several human pathogenic viruses, bacteria, and protozoa, transport proteins and 
other molecules, known as effectors, to the different compartments of eukaryotic host 
cells, including the cytoplasm and nucleus to manipulate the cell’s machinery to their 
advantage [197]. The mechanisms that bacteria use to survive within host cells include 
hijacking of cell signaling pathways (MAPK, G-proteins, and lipid signaling), the 
manipulation of actin and tubulin, targeting of ubiquitination, and possibly other 
unknown mechanisms [197,198]. One example of proteins that translocate into the 
nucleus of cells is the IpaH protein from Shigella flexneri, which is expressed by the 
bacteria only after entry into host cells, delivered into the cell cytoplasm and then 
translocated into the nucleus using the actin and tubulin machinery of mammalian cells 
[199]. This protein has been shown to reduce the activation of the nuclear factor ΚB (NF-
ΚB) by promoting ubiquitination of NEMO/IKKγ and leading to its degradation, thus 
affecting the inflammatory response of the host [200]. Like this protein, most effector 
proteins identified and described to date are secreted by Type Secretion Systems (TSS) I, 
II, III, and IV [201]. However, not all effectors and secreted proteins present TSS signal 
peptides and some are secreted using other systems, e.g., through their own transport 
channels or via outer membrane vesicles [202].   
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 Like most intracellular pathogens, A. phagocytophilum has been shown to secrete 
effector proteins into the cytoplasm and nucleus of its mammalian host cell [73,188]. A. 
phagocytophilum is an obligately intracellular bacterium that develops in neutrophil 
granulocytes and their bone marrow progenitors [183]. Neutrophils are highly efficient 
phagocytes and play an important role in the innate immune system. To survive and 
replicate in this normally hostile environment, A. phagocytophilum has evolved several 
mechanisms, including the injection of effectors [48]. The A. phagocytophilum genome 
encodes homologs of the T1SS and T4SS found in other bacteria [48]. But the two 
effectors described to date in A. phagocytophilum, i.e., AnkA and Ats-1 [48,73,188], are 
secreted by the T4SS. AnkA is a 160 kDA protein that is secreted into the cytoplasm of 
neutrophils and then translocated into their nucleus [73] where it binds to DNA and 
nuclear proteins [73]. In the nucleus AnkA binds to AT-rich regions of the CYBB 
promoter causing a decrease in the acetylation of histone 3 (H3), thus modulating the 
expression of the promoter and several immune genes including RAC2, MPO, 
BPI, and MYC [104].  
Even though AnkA is the only A. phagocytophilum protein that has been shown to 
be translocated into the nucleus and affect host cell gene expression, it is likely that its 
genome encodes additional nuclear effector proteins. In the present study, I used IFAs to 
show that the hypothetical protein APH_0906 was expressed early during infection in 
bacteria adherent to host cells. As infection of the cells progressed, secretion of the 
protein into the cytoplasm became obvious (Figures 3 and 4), and in heavily infected 
cells, the protein was subsequently translocated into the nucleus (Figure 2 and 3). The 
distribution of the protein in the nucleus appeared to follow diffused structures perhaps 
132 
 
 
representing chromatin or nucleoprotein (Figure 3 and 4). In RF/6A and HL-60 cells that 
had been transfected to express the entire Aph_0906 protein (Figure 6 and 7), the same 
pattern was observed, suggesting that the translocation of the protein was dependent on 
the host cell machinery and was independent of the presence of the pathogen in the cells.  
In eukaryotes, proteins with molecular mass of > 50 kDa cannot pass unaided 
through the nuclear membrane and require NLSs in order to be translocated into the 
nucleus [201]. NLSs consisting of one (monopartite) or two (bipartite) short amino acid 
sequences rich in positively charged amino acids (K and R) are recognized by carriers of 
the importin family (α or β) which effect translocation into the nucleus [201]. 
Intracellular pathogens exploit the host cell machinery by including NLSs within 
bacterial effector amino acid sequences [201]. However, the NLSs present in many 
bacterial effector proteins can differ from the standard NLSs found in eukaryotes, making 
it difficult for software to correctly predict the localization of many of these effector 
proteins [203]. This is true for 49 effector proteins in Helicobacter pylori, which 
according to Psortb, a bacterial protein localization predictor, are assigned to the 
cytoplasm, inner membrane, or outer membrane of the bacteria and not predicted to be 
secreted into the host cell [203].  These proteins were then analyzed for the presence of 
NLSs, based on amino acid composition, and then experimentally shown to localize to 
the nucleus of COS-7 cells transfected to express these effectors [203]. The Artemis 
genome browser used for tiling array analysis [54] and my research presented in Chapter 
2, predicted APH_0906 to be an outer membrane protein and a signal peptide for its 
secretion was not identified. However, the IFA experiments employing infected cells as 
well as APH_0906 transfected cells demonstrated that the protein was being secreted and 
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translocated into the cytoplasm and nucleus of host cells. Therefore, I used 
ProteinPredict, the program that had successfully identified NLSs in H. pylori to further 
examine the status of this protein and its homologs in several strains of A. 
phagocytophilum. Unlike CELLO and Psortb, ProteinPredict and a suite of different 
bioinformatics software programs suggested that all APH_0906 homologs were secreted 
and contained several NLSs (Table 1). 
The variations in the NLSs present in APH_0906 homologs from A. 
phagocytophilum isolates derived from different hosts prompted an analysis of any anti-
repressor (BRO-like) sequences and the positioning of putative protein binding sites 
within the protein. All APH_0906 homologs except that in CRT38 (Ap-Variant 1) 
possessed the BRO-like anti-repressor sequence (Table 1 and Figure 9). Research 
examining the phylogenetic relationship of ankA genes in A. phagocytophilum strains 
from different hosts showed that the ankA genes from isolates of human origin clustered 
in a group together with dog, horse, deer, cat, and sheep strains. By contrast, ankA genes 
from roe-deer associated strains not known to be pathogenic to humans clustered in 
groups distant from human pathogenic strains [204]. Moreover, AnkA proteins from the 
divergent clusters contained different numbers of ankyrin repeats, which are postulated to 
mediate interactions with other proteins [204]. My analysis of APH_0906 homologs 
similarly indicated that the Ap-Variant 1 protein from a strain infectious for white-tailed 
deer (a close relative to European roe deer) diverged from APH_0906 cluster 
representing isolates from humans, a dog, and jumping mouse (Figure 8). When the 
putative protein binding sites from each of the homologs were analyzed, the dog, jumping 
mouse, and HGE1 (isolated from a human in WI) showed the most similarity, with only 
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one small region at the beginning of the HGE1 protein being different from the other two 
homologs (Figure 9). While the pathogenicity of the Dog2 and JM (jumping mouse) 
strains for humans has not been proven, they are clearly related. By contrast, the Ap-
Variant 1 has not been associated with human cases of anaplasmosis and cannot infect 
mice or HL-60 cells experimentally [205],  It is possible that similarly to AnkA proteins, 
the sequence and structures of the different APH_0906 homologs depend on the host 
cells which the strains infect. It was surprising that the APH_0906 homolog from the 
human isolate HZ differed from all others with respect to protein binding sites.  Ap-
Variant 1 showed the same central and C-terminal binding regions in the sequence as did 
isolates JM, Dog2 and HGE1 (although minor differences were seen at the N-terminus), 
whereas the protein binding sites in HZ APH_0906 were distributed throughout the 
whole sequence with no pattern evident (Figure 9). Since the sequence of the APH_0906 
homolog of A. phagocytophilum HGE (the transposon mutant with the disrupted 
aph_0906 gene used here) has not been determined, the exact structure, localization, and 
presence or absence of a BRO-domain and NLSs in the protein is unknown. Although it 
is tempting to speculate that the BRO-domain and other features are conserved in the 
APH_0906 of HGE2, the differences in the homolog from isolate HZ demonstrate that 
human-derived isolates may not all conform to each other.   
The results presented here and in Chapter 2 suggest that APH_0906 is an A. 
phagocytophilum effector protein that is secreted into the cytoplasm of neutrophils and 
possibly endothelial cells and is translocated into the nucleus using the host cell 
machinery. Once in the nucleus, it is possible that APH_0906 binds to specific DNA 
sequences that are repeated throughout the genome or to proteins that recognize specific 
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DNA sequences in the host nucleus in a similar manner as that shown for AnkA [206]. 
Whether APH_0906 plays a role in host-specificity of A. phagocytophilum remains to be 
determined. Additional sequences from different strains that have shown human or non-
human specificity will need to be analyzed to draw a conclusion.  
 
Conclusion 
 In conclusion, APH_0906 is a protein secreted into the nucleus of host cells where 
it appears to interact with specific regions of the DNA or with specific host nuclear 
proteins. The sequence, structure, and presence of known DNA binding-motifs appears to 
change depending on the host species that the strain infects and anti-repressor (BRO-
domain) was lacking from a strain not known to infect humans. Using random 
mutagenesis, we have identified a hypothetical protein predicted to localize to the 
bacterial outer membrane, which is consistent with  experimental evidence that it is 
secreted and translocated into the nucleus. These studies support the validity of functional 
genomic analyses based on random mutagenesis to identify genes involved in bacterial 
pathogenesis of human anaplasmosis.   
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Figures and Tables 
 
Figure 1. PIM-0906core plasmid. 
 Plasmid used for the transfection of HL-60 and HMEC-1 cells. The plasmid 
contains the entire aph_0906 coding region (lighter blue arrow) driven by the CAGGS 
promoter (red arrow). The EM7 (yellow arrow) promoter drives the kanamycin/neomycin 
(dark blue arrow) resistance gene and a polyA signal (light blue) at the end of the 
resistance gene. All these genes were flanked by two IR/DR repeats (pink blocks) 
recognize by the transposase.  
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Figure 2. SB11 Plasmid.  
 Map available in the addgene website (http://www.addgene.org/26552/). The blue 
arrow (ORF frame 2) represents the full coding sequence for the optimized Sleeping 
Beauty version 11 [193]. The green arrow (CMV) represents the position of the CMV2 
promoter which contains an intron (red box) for optimal expression of the protein. The 
red arrow represents the ampicillim resistance gene for selection in E. coli.  
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Figure 3. Immunofluorescence Assays showing the localization of the hypothetical 
protein APH_0906 in HL-60 cells during infection with A. phagocytophilum 5 days 
after inoculation.  
 Hypothetical protein Aph_0906 labeled using serum raised against the first half of 
the protein (r1APH0906) is shown in the first column with the red channel (first column). 
A. phagocytophilum was labeled using serum against whole bacteria and is shown in the 
green in the second column). Bacteria are pointed at in all infected cells by green arrow 
heads. The nuclei of the cells and bacteria were labeled with DAPI and are shown in the 
blue channel (third column). The fourth column shows all channels combined. All cells 
presented in the figure represent cells from unsynchronized heavily infected cultures at 
different levels of infection. A) Cell with several internalized bacteria forming morulae. 
B) and C) cells with several morulae forming bacteria and some extracellular (bound and 
unbound) bacteria. D) Uninfected HL-60 cells (control). 
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Figure 4. Immunofluorescence Assays showing the localization of the hypothetical 
protein APH_0906 in HL-60 cells with A. phagocytophilum synchronized infection. 
Hypothetical protein Aph_0906 labeled using serum raised against the first half of 
the protein (r1APH_0906) is shown in the first column with the red channel (first 
column) in most panels.  Pre-immunized serum was used on infected cells as negative 
control. A. phagocytophilum was labeled using serum against whole bacteria and is 
shown in the green channel (the second column). Bacteria are pointed at in all infected 
cells by green arrow heads. The nuclei of the cells and bacteria were labeled with DAPI 
and are shown in the blue channel (third column). The fourth column shows all channels 
combined. HL-60 cells infected with cell-free  A. phagocytophilum for synchronization of 
the cultures. A and B) 24 hr, C) 12 hr,  and D) 1.5 hr. E) Shows the negative control 
consisting of uninfected HL-60 cells incubated with r1APH_0906 serum. F) Infected 
cells incubated with pre-immune mouse serum. 
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Figure 5. Western blots of transfected cells expressing APH_0906 detected with 
r1APH0906 serum against the first half of the protein.  
A) First transfection event WB shows RF/6A cells transfected only using the 
PIM0906 core plasmid without the transposase. B) The second transfection event WB 
shows the protein band in RF/6A and HL-60 cells transfected with both the PIM0906 
core and SB11 plasmid containing the Sleeping Beauty transposase. The red arrow points 
at the APH_0906 band. 
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Figure 6. Translocation of APH_0906 to the nucleus of transfected RF/6A cells.  
APH_0906 within transfected cells was labeled using antibodies against the first 
half of the protein (r1APH_0906) and then detected using FITC-labeled anti-mouse 
antibodies. The localization of the protein is shown in green fluorescence (First column), 
whereas the nucleus is shown by DAPI staining in the blue channel (Second column). 
The third column shows the combined channels. The fifth row shows wild-type RF/6A 
(control) cells incubated with r1APH_0906 antibodies. 
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Figure 7. Translocation of APH_0906 to the nucleus of transfected HL-60 cells 
 
 APH_0906 within transfected cells was detected using antibodies against 
the first half of the protein (r1APH_0906) and then labeled using Cy3-labeled anti-mouse 
antibodies. The localization of the protein is shown in red fluorescence (First column), 
whereas the nucleus is shown by DAPI staining in the blue channel (Second column). 
The third column shows the combined channels.   
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Table 1. Differences in sizes and Nuclear Localization Signals (NLS)s between strains of A. phagocytophilum. 
Strai
n Host Size 
BRO 
Anti-
represso
r Sequences NLS Predictor 
Positio
n  P-sort  
PP** 
(Bacteria
) 
PP** 
(Eukaryotic
) Nuc-Ploc 
HZ Human 
152
8 yes 
YRTAVKKVKLA 
ENAVKERMLPALTLYAKRIAKR 
KGTDGKKPSTTVPKKPPRPARGAK 
NLSMAPPER 
NLSMAPPER 
NLStradamus 
202 
647 
1451 OM* Secreted Cytoplasm Nuclei  
HGE
1 Human 
152
8 yes 
YRTAVKKVKLA 
ENAVKERMLPALTLYAKRIAKR 
DGKKPSTTVPKKPPRPARGAK 
NLSMAPPER 
NLSMAPPER 
NLStradamus 
202 
647 
1454 OM* Secreted Cytoplasm Nuclei  
JM 
Jumpin
g 
Mouse 
149
1 yes 
YRTAVKKVKLA 
DLRKRHRWA 
ENAVKERMLPALTLYAKRIAKR 
DGKKPSTTVPKKPPRPARGAK 
NLSMAPPER 
NLSMAPPER 
NLSMAPPER 
NLStradamus 
165 
388 
610 
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Figure 8. Similarities and relationship between Aph_0906 homologs in different A. 
phagocytophilum strains.  
A) Phylogenetic tree showing the relationship between the homologs of the protein 
APH_0906 from 5 different strains of A. phagocytophilum. 0906 represents the protein present 
in the HZ strain. Phylogenetic tree was constructed using alignment of the predicted amino 
acid sequences from A. phagocytophilum strains, which have been sequenced and are available 
in GenBank. The relationship of the protein sequences was inferred using Neighbor Joining 
and the total number of differences to determine the length of the branches. The numbers at the 
nodes represents the bootstrap value from 1000 replications. B) Similarity matrix showing the 
identity scores of the different amino acid sequences from the APH_0906 homolog present in 
each of the A. phagocytophilum strains. 
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Figure 9. Binding sites, secondary structure, and solvent accessibility of the Aph_0906 
homologs present in 5 strains of A. phagocytophilum.  
The black line and the numbers represent the number of the residue in the linear form 
of the amino acid sequence. The positions of binding sites in the different homologs are shown 
by the red pins. The red squares, below the binding sites, represent the residues that form α-
helices whereas the blue squares represent β-strands. The third row shows the exposed (yellow 
squares) and the hidden (blue squares) residues on the proteins.  
 
 
 
149 
 
 
Summary 
  Two A. phagocytophilum mutants that present phenotypical changes in their ability to 
infect tick or mammalian cells were produced using the HIMAR transponson-transposase 
system. The transposition sites were determined to have occurred in a gene that encodes a O-
methyltransferase, referred to the OMT-mutant, and in the gene aph_0906 that encodes a 
hypothetical protein, referred to APH0906-mutant. The OMT-mutant failed to grow in ticks 
cells and the bacteria were rapidly degraded, showing a decrease in bacterial numbers at 24 hr 
p.i. In contrast, the APH0906-mutant was not able to grow in HL-60 cells but the bacterial 
numbers remained the same throughout the 5 days of the experiment. PCR showed that the 
APH0906-mutant was able to infect and persist in hamsters for up to 21 days.   
Gene expression analyses of the OMT coding gene showed that the gene is upregulated 
during binding and internalization at 1 – 2 hr p.i. The OMT-mutant failed to bind to ISE6 cells 
(tick cells). Further analyses showed that inhibition of methyltransferases in wild-type 
A.phagocytophilum, using an S-adenosyl-homocysteine hydrolase inhibitor (Adenosine 
Periodate (Adox), resulted in a similar phenotype. Immuno Fluorescent Assays (IFAs) 
determined that the OMT was expressed by A. phagocytophilum when the bacteria were 
invading tick cells. Proteomic analyses identified several proteins, known to be expressed 
during tick infection, that were downregulated in the OMT-mutant during binding to tick cells 
whereas that several proteins suspected to be important for infection of mammalian cells were 
upregulated. This proteomic analysis also identified several proteins that were not methylated 
in the OMT-mutant. In vitro methylation assays identified the Major Surface Protein 4 (Msp4) 
as the substrate for the OMT. Thus, suggesting that methylation in Msp4 is important for A. 
phagocytohilum binding to and infection of tick cells. 
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Analyses of aph_0906 gene expression showed that the gene is upregulated during later 
phases of infection and the effect on binding was not as pronounced. Bioinformatic analyses of 
the gene showed that the protein presents several DNA binding sites. Localization experiments 
of the protein using IFAs of infected cells demonstrated that the protein localizes to the 
bacteria when A. phagocytophilum was outside of the cell and during binding. However, when 
the bacteria were inside of HL-60 cells, the protein was secreted into the cytoplasm and as the 
infection progressed the protein was found in the nucleus of the host cells. Likewise, RF/6A 
and HL-60 cells transformed to express the APH_0906 protein showed a similar translocation 
of the protein to their nuclei. Bioinformatic analyses of the protein showed several Nuclear 
Localization Signal (NLS) sequences within APH_0906 and also identified several differences 
in these NLSs in the homologs of this protein within strains of A. phagocytophilum that present 
different host-tropisms. These results suggest that APH_0906 may be an effector molecule in 
A. phagocytophilum important for infection of human cells. 
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